Submit a Manuscript
F6Publishing
Publisher Login
Manuscript Statistics
Articles In Press
1
Haddiya I, Simanjuntak GDFI, Ramdani S. Updates in the management of intradialytic hypotension: Emerging strategies and innovations. World J Nephrol 2025; In press
2025-09-17 | Browse: 10 | Download: 0
2
Prabhahar A, Vijaykumar NA, Kaur H, Sharma N, Pannu AK. Baseline predictors of in-hospital mortality among patients with chronic kidney disease admitted to the emergency department. World J Nephrol 2025; In press
2025-09-17 | Browse: 5 | Download: 0
3
Devulapalli CS. Modulatory role of vitamin D in atopic dermatitis and allergic rhinitis. World J Clin Pediatr 2025; In press
2025-09-17 | Browse: 14 | Download: 0
4
Zhang JW. Predicting steroid response in acute alcohol-associated hepatitis: Beyond biomarkers of alcohol consumption. World J Hepatol 2025; In press
2025-09-17 | Browse: 2 | Download: 0
5
Popat A, Vempati R, Kodali LSM, Mrudula ASS, Haddad F, Jain A, Krishnamoorthy G, Sharma P. Frailty status and outcomes of percutaneous coronary intervention in elderly patients with non-ST-elevation myocardial infarction. World J Cardiol 2025; In press
2025-09-17 | Browse: 19 | Download: 0
6
English K. Drug-induced liver injury from high-dose intravenous methylprednisolone: A rare but known adverse effect. World J Gastrointest Pathophysiol 2025; In press
2025-09-17 | Browse: 6 | Download: 0
7
Khawar M, Shah SA, Khan A, Waseem A, Saeed H, Fatima A, Saifullah M, Mehdi AM, Qadeer A, Hadeed Khawar MM. Posterior pericardiotomy: An effective strategy for reducing post-coronary artery bypass grafting complications, with considerations for pleural effusion risk. World J Cardiol 2025; In press
2025-09-17 | Browse: 3 | Download: 0
8
Wankhade BS, El Kholi MHIA, Alrais ZF, Elkhouly AES, Naidu GAK, Patel AA, Sameer M, Abbas MS, Elbasier NNF, El Hadi AF. Acute kidney injury in the critically Ill traumatic brain injury patients: A single center retrospective cohort study. World J Crit Care Med 2025; In press
2025-09-17 | Browse: 2 | Download: 0
9
Liu JW, Chen WJ, Lan YZ, Liu J. Catalase: The golden key to regulate oxidative stress in breast cancer. World J Clin Oncol 2025; In press
2025-09-17 | Browse: 12 | Download: 0
10
Ngo TH, Tran SK. Role of polymorphisms and microRNA levels in predicting cardiovascular events in patients with acute myocardial infarction. World J Cardiol 2025; In press
2025-09-17 | Browse: 47 | Download: 0
11
Li ZK, Liao JL, Luo MR, Fang SJ, Huang WZ, Zhang DY. Neuro-tumor interactions: Multi-dimensional mechanisms of neurotransmitter regulation in tumor immune evasion and metabolic reprogramming. World J Clin Oncol 2025; In press
2025-09-17 | Browse: 26 | Download: 0
12
Agnello F, Taibbi A, Galia M, Orlando A, Gagliardo C, Bartolotta TV. Hepatocellular carcinoma treatment response: Imaging findings and criteria. World J Radiol 2025; In press
2025-09-17 | Browse: 2 | Download: 0
13
Swarnakar R, Yadav SL. Cancer rehabilitation in India: Current status, scope, and future perspectives. World J Clin Oncol 2025; In press
2025-09-17 | Browse: 14 | Download: 0
14
Loschi TM, Baccan MDTA, Pereira EC, Dellabarba TDLC, Boteon APCS, Boteon YL. Telerehabilitation for frail cirrhotic patients awaiting liver transplant: A safe, effective strategy to improve outcomes. World J Hepatol 2025; In press
2025-09-17 | Browse: 6 | Download: 0
15
Ahmed El-Imam IA, Peter TA, Fussi HF, Ally ZM, Bakari HM, Mbwana MS, Chenya UK, Mpimo BK, Ally HM, Ramadhani HO. Human immunodeficiency virus recency testing coverage and partner-notification-services among people-living with human immunodeficiency virus in low- and middle-income countries. World J Virol 2025; In press
2025-09-17 | Browse: 10 | Download: 0
16
Ai-Si-Ka-Er AKD, Sun MM, Shen J. Positron emission tomography/computed tomography in risk-factor-negative young female with malignant pleural mesothelioma: A case report and review of literature. World J Clin Cases 2025; In press
2025-09-17 | Browse: 12 | Download: 0
17
Adeva-Andany MM. Beneficial effect of sodium-glucose cotransporter 2 inhibitors on kidney function can be just a mirage. World J Nephrol 2025; In press
2025-09-17 | Browse: 4 | Download: 0
18
Zhang MY, Yao JJ, Pan SX, Hou WW, Wei X, Zhao XL, Fu JD. Sessile serrated lesions involving the appendiceal orifice: Endoscopic diagnosis and treatment. World J Gastrointest Endosc 2025; In press
2025-09-17 | Browse: 2 | Download: 0
19
Zhuge WW, Zheng LX, Xu LJ, Zhou SF, Yao HX. Effect of amino acid-balanced diet-based nutritional-psychological intervention on muscle wasting and quality of life in cirrhosis patients. World J Psychiatry 2025; In press
2025-09-17 | Browse: 6 | Download: 0
20
Zhou SQ, Ke QH. Advancing precision in hepatocellular carcinoma prognostication: The promise of biparametric magnetic resonance imaging-based multimodal models. World J Hepatol 2025; In press
2025-09-17 | Browse: 26 | Download: 0
694 items  Read more >>
Author Reviews
1
"I am writing to express my sincere appreciation for publishing my work. The entire process was smooth and remarkably efficient, ..."  [Read more]
"I am writing to express my sincere appreciation for publishing my work. The entire process was smooth and remarkably efficient, facilitated by a highly professional team. Furthermore, fostering interdisciplinary dialogues could attract a wider readership and spark innovative research. My best wishes for the journal's continued success and growing impact on the global academic community. "  [Collapse]
Chen X, Sun XH, Xiao Y, Zhang D, Lu XY, Fu CL, Bi C, Wang X. Efficacy and safety of transarterial chemoembolization with chemotherapy, PD-1/PD-L1 inhibitors, and tyrosine kinase inhibitors in unresectable intrahepatic cholangiocarcinoma. World J Gastrointest Oncol 2025; 17(9): 103816
2
"During the review process of the manuscript, the opinions provided by the reviewers were very practical. They helped me improve many ..."  [Read more]
"During the review process of the manuscript, the opinions provided by the reviewers were very practical. They helped me improve many deficiencies in the article, expand the research scope, and increase the richness of the paper. I am extremely grateful for your assistance. At the same time, I would like to express my sincere gratitude to the editors for their hard work.Best wishes to you. "  [Collapse]
Sun TF, Fan KX, Luo YX, Song J, Han ZX, Zhang XL. Relationship between uric acid and colon cancer risk: Dose-response analysis and mechanisms. World J Gastrointest Oncol 2025; 17(9): 107651
3
"A very rigorous and intensive peer review was prepared by the journal. The journal interface for revision submission was also very ..."  [Read more]
"A very rigorous and intensive peer review was prepared by the journal. The journal interface for revision submission was also very extensive and detailed, but smooth. The manuscript proofreading process was also detailed and minute. The overall quality of the PDF produced is also excellent. We are thankful to the editorial team for such a pleasant experience. "  [Collapse]
Gupta S, Lal N, Pradhan A, Verma AK. Association of chronic periodontitis in a broad spectrum of cardiometabolic syndrome: A minireview. World J Cardiol 2025; 17(9): 109126
4
"The publication time was relatively long (4 months). I think the journal should target reducing the time between acceptance and ..."  [Read more]
"The publication time was relatively long (4 months). I think the journal should target reducing the time between acceptance and publication. It is understandably that if quality will be better, it may take longer time. Nevertheless, increasing the staff may shorten this time which can increase the citation of the manuscript. "  [Collapse]
Abu-Zidan FM, Idris K, Cevik AA. Management of earthquake-related acute renal injury. World J Nephrol 2025; 14(3): 107201
5
"I wish express our profound appreciation to the entire stakeholders of the World Journal of Nephrology for extending their kind ..."  [Read more]
"I wish express our profound appreciation to the entire stakeholders of the World Journal of Nephrology for extending their kind invitation and accepting our proposed manuscript title and abstract in the first instance. The editorial process from the submission to the publication was exciting and filled with a great and worthwhile experience. You have maintained a satisfactory ethical standard worthy of emulation by other peer-reviewed Journal. "  [Collapse]
Khalid A, Yakubu KB, Umar AM, Aljannare BG, Aminu NA, Obadele OG, Abdulwahab-Ahmed A. Uncommon presentation and management of a giant renal cyst abscess: A case report. World J Nephrol 2025; 14(3): 108703
6
"World Journal of Nephrology has a robust and reasonably good peer-review process. It offers a viable and credible venue for publication ..."  [Read more]
"World Journal of Nephrology has a robust and reasonably good peer-review process. It offers a viable and credible venue for publication for researchers, especially in the field of nephrology. The journal is committed to ethical standards, timely processing, external review, and clarity in author instructions. I suggest that there will be public peer-review reports on the journal website in the future. "  [Collapse]
Tran TTT, Tran KV, Nguyen TD, Pham NTT, Nguyen TH. Role of heat shock proteins in renal function and adaptation to heat stress: Implications for global warming. World J Nephrol 2025; 14(3): 107571
7
"Dear Chief Editor and Esteemed Reviewers, Greetings of the day. Thank you so very much for publishing our manuscript in your ..."  [Read more]
"Dear Chief Editor and Esteemed Reviewers, Greetings of the day. Thank you so very much for publishing our manuscript in your prestigious PubMed Journal. We are very much obliged for the great efforts done by the reviewers, editors and the publication team. Their actions had greatly improved the overall scientific and academic quality of our manuscript upto highest international standards. Hopefully this unique manuscript will garner lots of citation in the scientific community. Thanks for the opportunity. Best Regards, Dr . Arvind Kumar Morya MS(Gold Medalist) MNAMS Additional Professor & Unit-I Head Cataract, Glaucoma, Refractive, Squint Paediatric Ophthalmology and Medical Retina Services Associate Editor UKJOS, National Advisor IJO,GJCSRO Editorial Board Member IJOVS, WJCC, EC-Ophthalmology, DOS Times, Journal of HOS. Reviewer Elsevier, AIMDR and IJO Clinical Trial Expert Panel - CDSCO & Ministry of Health and Family Welfare Convenor - AIOS Adverse Event Committee Department of Ophthalmology All India Institute of Medical Sciences, Bibinagar Hyderabad, Telangana -508126 INDIA +91-8003996598 "  [Collapse]
Menia NK, Morya AK, Gupta PC, Ramachandran R. Ocular biomarkers in diabetes mellitus with diabetic kidney disease: A minireview. World J Nephrol 2025; 14(3): 109470
8
"I wish to express my sincere appreciation to you, the editorial office, and all reviewers for the exceptional collaboration throughout ..."  [Read more]
"I wish to express my sincere appreciation to you, the editorial office, and all reviewers for the exceptional collaboration throughout the peer-review process of my manuscript. Your professionalism, clear guidance, and timely communication greatly facilitated revisions and improvement. The quality of feedback and supportive correspondence not only improved the scientific rigor of my work but also made the experience highly constructive. I am grateful for the care and dedication you invest in your role. "  [Collapse]
Kapritsou M. Intersection of medicine and nursing in endoscopic sedation: Understanding roles and responsibilities. World J Gastrointest Endosc 2025; 17(9): 110664
9
"It was a pleasant experience working on this manuscript, as the peer review committee was prompt to respond and always gave good ..."  [Read more]
"It was a pleasant experience working on this manuscript, as the peer review committee was prompt to respond and always gave good feedback for improvement. From editing to proofreading to the online portal system to make changes, all the processes were seamless. I thoroughly enjoyed my time working with the committee to get this manuscript to be published and would recommend the same committee to any aspiring author. "  [Collapse]
Majmundar V, Deo R, Mishra AK, Li PY, Byer M, Sancassani R. Transcatheter atrial septal defects and patent foramen ovale closure: Medicare utilization and reimbursements. World J Methodol 2025; 15(4): 103146
10
"We received many thoughtful and highly appropriate comments from the reviewers. Through the revision process, I truly felt that the ..."  [Read more]
"We received many thoughtful and highly appropriate comments from the reviewers. Through the revision process, I truly felt that the manuscript was continuously refined and improved. Moreover, I was amazed by the prompt handling after the revision and that the acceptance was reached within just a matter of days. I am deeply grateful for the journal’s swift and appropriate response. "  [Collapse]
Sugiyama Y, Tanabe K, Yanagawa S, Tazawa H, Toyota K, Kano M, Misumi T, Shishida M, Okano K, Hotta R, Ota H, Imaoka Y, Fukuda T, Takahashi S, Ohdan H. Prognostic factors and efficacy of postoperative chemotherapy in patients with gastric cancer with positive peritoneal cytology after gastrectomy. World J Gastrointest Oncol 2025; 17(9): 110245
11
"This journal offers a rapid review process, and the reviewers provide fair and constructive comments. The figures and tables prepared ..."  [Read more]
"This journal offers a rapid review process, and the reviewers provide fair and constructive comments. The figures and tables prepared by the authors are well-formatted and easily editable. It would be even better if the time from manuscript receipt to online publication could be further shortened. In short, this journal is a worthwhile venue for scholars engaged in gastrointestinal cancer research. "  [Collapse]
Zhan TA, Xia F, Huang HW, Zhan JC, Liu XK, Cheng Q. Fibroblast growth factor 19-fibroblast growth factor receptor 4 axis: From oncogenesis to targeted-immunotherapy in advanced hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(9): 108649
12
"I would like to sincerely thank the editorial team and peer reviewers for their professional and constructive support throughout the ..."  [Read more]
"I would like to sincerely thank the editorial team and peer reviewers for their professional and constructive support throughout the entire publication process. The peer review comments were insightful and helped to significantly improve the quality and clarity of our manuscript. The editorial handling was efficient, transparent, and highly professional, resulting in a smooth and rewarding publication experience. I am very satisfied with the overall process and would be pleased to recommend this journal to my colleagues. "  [Collapse]
Kim JH, Na HY, Jung K, Jang D, Youn Y, Kim DH, Han HD, Hwang JH. Quantitative immunohistochemistry analysis of pancreatic adenocarcinoma upregulated factor expression in pancreatic cancer and its prognostic significance. World J Gastrointest Oncol 2025; 17(9): 109055
13
"This was an exceptional publication experience from start to finish. The journal's reputation for rigorous scholarship is ..."  [Read more]
"This was an exceptional publication experience from start to finish. The journal's reputation for rigorous scholarship is well-deserved, as evidenced by the insightful and constructive comments from the reviewers, which greatly enhanced our manuscript. The editorial team was remarkably efficient and communicative at every stage, ensuring a smooth and transparent process. The rapid transition from acceptance to online publication is also highly commendable. I would look forward to submitting future work. "  [Collapse]
Zhang X, Chen DB, Zhang R, Chen P, She SP, Yang Y, Ren LY, Chen HS. Immune checkpoint molecules signal regulatory protein alpha in the development of hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(9): 109824
14
"I would like to express my sincere appreciation to the editorial team for their highly efficient handling of my manuscript. The ..."  [Read more]
"I would like to express my sincere appreciation to the editorial team for their highly efficient handling of my manuscript. The peer-review process was both rigorous and exceptionally swift, with constructive feedback that significantly improved the quality of the work. Moreover, the time from acceptance to online publication was remarkably short, reflecting the journal’s strong commitment to rapid dissemination of high-quality research. It has been a truly smooth and rewarding experience publishing in this journal. "  [Collapse]
Qiu ZS, Wang XC, Ma JC, Zhu CL, Hu YL, Da MX. DEAD/H-box RNA helicase 10 promotes pancreatic cancer cell proliferation via ribonucleotide reductase M2. World J Gastrointest Oncol 2025; 17(8): 108672
15
"My experience with this journal’s acceptance process was largely positive. The initial submission was streamlined via its user-friendly ..."  [Read more]
"My experience with this journal’s acceptance process was largely positive. The initial submission was streamlined via its user-friendly online portal, with clear guidelines reducing confusion. Post-submission, the status updates were timely, so I never felt in the dark. The peer reviews, though rigorous, were constructive—suggestions focused on strengthening arguments rather than nitpicking. After I revised the manuscript, the editorial team responded promptly, finalizing the acceptance within two weeks. Minor hiccups, like a short delay in one review, were negligible. Overall, the process was transparent and efficient, showing the journal’s respect for authors’ work. "  [Collapse]
Deng QX, Tang XL, Yuan GJ, Jian Q, Chen XH, Wu LJ. Study of serum tumor markers in the early diagnosis of pancreatic cancer. World J Gastrointest Oncol 2025; 17(9): 106910
16
"Thank you for giving us the opportunity to provide feedback on our recent publication experience (Manuscript NO. 109378). Overall, ..."  [Read more]
"Thank you for giving us the opportunity to provide feedback on our recent publication experience (Manuscript NO. 109378). Overall, I am very satisfied with my publishing experience in the World Journal of Gastrointestinal Oncology. Below is our detailed evaluation: 1.Efficient editorial processing: The manuscript was promptly sent for peer review after submission, and status updates were provided in a timely manner at every stage. Communication from the editors was clear, professional, and supportive throughout the decision-making process. 2.High-quality review comments: The reviewers provided exceptionally constructive and insightful feedback. Although addressing their comments required considerable effort, their critiques greatly enhanced the scientific rigor and narrative clarity of our paper. 3.Rapid publication speed: The production process following acceptance was remarkably efficient, resulting in swift online publication. This rapid dissemination is vital for the timely sharing of our findings with the research community. 4.Online System Interface: The online submission system functions adequately. However, each resubmission currently overwrites the previous version of the manuscript. It would greatly improve the user experience if the interface could retain a record of all submitted versions. We are very satisfied with our experience publishing in the World Journal of Gastrointestinal Oncology. The rigorous peer review process and efficient production are hallmarks of a high-quality journal. Thank you again for your hard work. "  [Collapse]
Pu BP, Wang PH, Guo KK, Liu C, Chen SR, Li XM, Chen SM, Zeng XZ, Gao C. Rapamycin suppresses small bowel adenocarcinoma HUTU 80 cells proliferation by inhibiting hypoxia-inducible factor-1α mediated metabolic reprogramming. World J Gastrointest Oncol 2025; 17(9): 109378
17
"The publication process for my article went smoothly from start to finish. When I encountered small questions about document formatting ..."  [Read more]
"The publication process for my article went smoothly from start to finish. When I encountered small questions about document formatting or submission progress, the editorial team replied promptly with clear guidance. The peer review steps were also well-organized and followed a regular timeline, making the whole experience straightforward and without unnecessary delays. "  [Collapse]
Xiong FC, Luo MP, Ruan SM. Construction of a risk prediction model for early postoperative recurrence in stage II/III colorectal cancer. World J Gastrointest Oncol 2025; 17(9): 107968
18
"I am thoroughly satisfied with the peer review process provided by this journal. The reviewers' comments were exceptionally thorough, ..."  [Read more]
"I am thoroughly satisfied with the peer review process provided by this journal. The reviewers' comments were exceptionally thorough, insightful, and constructive. They demonstrated a deep understanding of the subject matter and provided critiques that significantly strengthened the manuscript's clarity and scientific rigor. The entire process was handled with remarkable professionalism and timeliness by the editorial team, making the revision phase both productive and intellectually rewarding. This experience was highly positive, and I would not hesitate to recommend this journal to my colleagues for its exemplary peer review standards. "  [Collapse]
Xue RX, Lu XY, Deng P, Wang LH, Yun YF. Misdiagnosis of gastric oxyntic gland adenoma as hyperplastic polyp: A case report. World J Gastrointest Oncol 2025; 17(9): 110505
19
"The journal editor has been extremely supportive throughout the submission and review process, providing helpful guidance and ..."  [Read more]
"The journal editor has been extremely supportive throughout the submission and review process, providing helpful guidance and facilitating a smooth communication. Likewise, the reviewers offered constructive and genuinely encouraging comments that highlighted the strengths of the manuscript while also suggesting valuable improvements. Their feedback significantly enhanced the overall quality of the work. I am sincerely grateful for their efforts, and I would like to express my heartfelt thanks for all the contributions and support provided during this process. "  [Collapse]
Kirkik D, Ozabaci AN, Kalkanli Tas S. Changing patterns of cholangiocarcinoma and gallbladder cancer: A regional perspective from Northeastern Italy. World J Gastrointest Oncol 2025; 17(9): 108578
20
"First of all, thank the editor for his hard work. The overall submission process of your magazine is fair and transparent. The opinions ..."  [Read more]
"First of all, thank the editor for his hard work. The overall submission process of your magazine is fair and transparent. The opinions and suggestions put forward by peer review experts are very professional. We have gained a lot in the process of submission. If there are suitable articles in the future, we will continue to contribute to your magazine. "  [Collapse]
Gao Z, Zhang JX, Tian XD, Wu SK, Jin X. Rapid cholestasis improvement as key strategy for steroid-refractory immune-related cholangitis: A case report. World J Gastrointest Oncol 2025; 17(9): 108960
19493 items  Read more >>
Article Quality Tracking-Peer-Review
1
"Although the disease is very rare nowadays, the article's information looks meaningful and informative. I have witnessed this disease ..."  [Read more]
"Although the disease is very rare nowadays, the article's information looks meaningful and informative. I have witnessed this disease in goats but not in humans. The published article has raised very good concerns by picking up this topic. This is the only way to get information about the disease, as it is very rare, or almost never witnessed by several doctors. In the article, the authors have very nicely discussed the pathogenicity and other aspects. "  [Collapse]
Ismail A, Abdelsalam MA, Shahin MH, Ahmed Y, Bahcecioglu IH, Yalniz M, Tawheed A. Hepatobiliary fascioliasis: A neglected re-emerging threat, its diagnostic and management challenges. World J Gastrointest Pathophysiol 2025; 16(2): 107599
2
"This study innovatively applied ResNet to the hepatic congestion signs in conventional CT, further diagnosing congestive liver ..."  [Read more]
"This study innovatively applied ResNet to the hepatic congestion signs in conventional CT, further diagnosing congestive liver diseases, and has clear value for early warning of liver injury in patients with HF. The methodology is rigorous, and it has confirmed that AI can assist in the early identification of TR-related liver injury. In the next step, it is necessary to expand the sample to verify the generalization, and strengthen the clinical transformation design."  [Collapse]
Miida S, Kamimura H, Fujiki S, Kobayashi T, Endo S, Maruyama H, Yoshida T, Watanabe Y, Kimura N, Abe H, Sakamaki A, Yokoo T, Tsukada M, Numano F, Kashimura T, Inomata T, Fuzawa Y, Hirata T, Horii Y, Ishikawa H, Nonaka H, Kamimura K, Terai S. Image analysis of cardiac hepatopathy secondary to heart failure: Machine learning vs gastroenterologists and radiologists. World J Gastroenterol 2025; 31(34): 108807
3
"This article focuses on esophageal GIST, a rare disease type (accounting for only 0.5% of all GIST cases), and systematically reviews ..."  [Read more]
"This article focuses on esophageal GIST, a rare disease type (accounting for only 0.5% of all GIST cases), and systematically reviews the potential of endoscopic resection techniques (ESD/STER/EFTR) to replace the highly invasive esophageal resection surgery. The next supplementary content includes: supplementing with endoscopic image evidence to clarify technical details; adding treatment strategies for special populations (children/immunosuppressed individuals); discussing the potential application of robot-assisted endoscopy."  [Collapse]
Krishnamoorthy A, Griffiths EA. Endoscopic resection of oesophageal gastrointestinal stromal tumours: Promise, pitfalls and the path forward. World J Gastroenterol 2025; 31(34): 110448
4
"This article focuses on the expanded application of the ALBI score in non-malignant liver diseases, systematically reviewing its ..."  [Read more]
"This article focuses on the expanded application of the ALBI score in non-malignant liver diseases, systematically reviewing its clinical value as an objective tool for liver function assessment. Its limitations lie in: inability to assess the degree of liver fibrosis; being affected by non-liver factors such as hemolysis and sepsis; and decreased reliability in cases of end-stage liver disease combined with renal failure."  [Collapse]
Demirors B, Shekouhi R, Jimenez PB, Yadav A, Chiriboga G, Mahesh VA, Manaise HK, Bowers J, Merly AA, Gabriel E. Redefining the albumin-bilirubin score: Predictive modeling and multidimensional integration in liver and systemic disease. World J Gastroenterol 2025; 31(34): 110602
5
"This article systematically integrates the latest evidence-based evidence for the imaging assessment of anorectal fistula type Crohn's ..."  [Read more]
"This article systematically integrates the latest evidence-based evidence for the imaging assessment of anorectal fistula type Crohn's disease (pCD), and for the first time proposes a multi-modal imaging stratified decision-making pathway, providing individualized solutions for different medical resource scenarios. The possible future directions include: developing an ultrasound scoring system; implementing AI models to adapt to portable ultrasound devices for use at the grassroots level; and remote image monitoring."  [Collapse]
Habeeb H, Chen L, De Kock I, Bhatnagar G, Kutaiba N, Vasudevan A, Srinivasan AR. Imaging in perianal fistulising Crohn’s disease: A practical guide for the gastroenterologist. World J Gastroenterol 2025; 31(34): 110611
6
"This study innovatively applied SR reconstruction to the prediction of liver cancer pathological grading, confirming that SR-MRI can ..."  [Read more]
"This study innovatively applied SR reconstruction to the prediction of liver cancer pathological grading, confirming that SR-MRI can enhance the prediction efficacy of liver cancer pathological grading. The method is rigorous and the conclusion is reliable, providing a new idea for radiomics. However, it is necessary to strengthen the design of clinical transformation pathways and the exploration of biological mechanisms. The next step should focus on prospective validation and multi-omics integration."  [Collapse]
Wang ZZ, Song SM, Zhang G, Chen RQ, Zhang ZC, Liu R. Multiparametric magnetic resonance imaging of deep learning-based super-resolution reconstruction for predicting histopathologic grade in hepatocellular carcinoma. World J Gastroenterol 2025; 31(34): 111541
7
"A transjugular intrahepatic portosystemic shunt (TIPS) is one of the most challenging procedures in interventional radiology. Hepatic ..."  [Read more]
"A transjugular intrahepatic portosystemic shunt (TIPS) is one of the most challenging procedures in interventional radiology. Hepatic and portal venous anatomy can vary greatly, and access to the portal vein, which can be quite difficult even for experienced surgeons, is the most critical step in a TIPS. Despite the fact that there are many techniques for clearly identifying the relevant anatomic structures during TIPS creation, each of them carries a unique set of risks and benefits. Thus, knowledge of these techniques will empower the surgeon in planning and subsequently performing a TIPS and, ultimately, increase the likelihood of a safe and successful procedure."  [Collapse]
Miao L, Ren JL, Zhao H, Li X. Optimal guiding methods for transjugular intrahepatic portosystemic shunt creation: Characteristics of intravascular ultrasound vs other techniques. World J Hepatol 2025; 17(8): 109496
8
"It was with pleasure that I tracked the quality of the following article. Please see my comments below: 1 Ethics: Not applicable ..."  [Read more]
"It was with pleasure that I tracked the quality of the following article. Please see my comments below: 1 Ethics: Not applicable given manuscript type 2 Methods: Not applicable given manuscript type 3 Results: Not applicable given manuscript type 4 Figures and tables: The figures/tables enhance the readability of the manuscript 5 Biostatistics: Not applicable given manuscript type 6 References: The references are appropriate/up-to-date 7 Language: This is a well-thought out comprehensive manuscript 8 Caveats or drawbacks: None "  [Collapse]
Habeeb H, Chen L, De Kock I, Bhatnagar G, Kutaiba N, Vasudevan A, Srinivasan AR. Imaging in perianal fistulising Crohn’s disease: A practical guide for the gastroenterologist. World J Gastroenterol 2025; 31(34): 110611
9
"This retrospective multicenter study aimed to investigate the type and rate of complications in patients undergoing SBE as well as ..."  [Read more]
"This retrospective multicenter study aimed to investigate the type and rate of complications in patients undergoing SBE as well as the risk factors responsible for the occurrence of these complications. The rate of complications (0.4%) was very low and concerned intestinal perforation, which was detected in all cases during the endoscopy. The treatment was surgical in all patients, and the outcome was favorable. The main risk factor for the occurrence of this complication was previous abdominal surgery and excessive abdominal pressure during endoscopy. SBE performed by experienced endoscopists is a remarkably safe method and should be applied in all cases of occult gastrointestinal bleeding. Endoscopists should be particularly careful in patients with previous surgery, in which the application of abdominal pressure is often necessary. In my opinion, this second reason is the most important for the occurrence of this complication. Gastroenterologists-endoscopists should be particularly careful when requesting the application of abdominal pressure during endoscopy. "  [Collapse]
Ullah S, Bai YQ, Wareesawetsuwan N, Cui LL, Danzhu YJ, Wang K, Zhu SS, He X, Cao XG, Guo CQ, Zhang FB. Complications of single-balloon enteroscopy: A nine-year multicenter experience of 2865 procedures. World J Gastroenterol 2025; 31(34): 110548
10
""A total of 179 patients with chronic HF who underwent echocardiography between 2011 and 2020 were included. These patients underwent ..."  [Read more]
""A total of 179 patients with chronic HF who underwent echocardiography between 2011 and 2020 were included. These patients underwent CT within 1 year before or after echocardiography; blood samples were collected within 6 months of imaging. The severity of right HF was classified into three groups (mild, moderate, and severe) based on a comprehensive echocardiographic assessment. Selected patient's diseases are unclear. Did authors select the patients who have ischemic coronary diseases, congenital heart diseases, or valvular diseases? Methods are new."  [Collapse]
Miida S, Kamimura H, Fujiki S, Kobayashi T, Endo S, Maruyama H, Yoshida T, Watanabe Y, Kimura N, Abe H, Sakamaki A, Yokoo T, Tsukada M, Numano F, Kashimura T, Inomata T, Fuzawa Y, Hirata T, Horii Y, Ishikawa H, Nonaka H, Kamimura K, Terai S. Image analysis of cardiac hepatopathy secondary to heart failure: Machine learning vs gastroenterologists and radiologists. World J Gastroenterol 2025; 31(34): 108807
11
"This is very interesting paper.The hepatic venous pressure gradient serves as a crucial parameter for assessing portal hypertension ..."  [Read more]
"This is very interesting paper.The hepatic venous pressure gradient serves as a crucial parameter for assessing portal hypertension and predicting clinical decompensation in individuals with cirrhosis. However, owing to its invasive nature, there has been growing interest in identifying noninvasive alternatives. Noninvasive models utilizing SSM, LSM, and SLD are effective in predicting clinical decompensation among patients with viral cirrhosis, I agree to author's opinion. "  [Collapse]
Yang LB, Gao X, Xu M, Li Y, Dong L, Huang XD, She X, Zhang DY, Zhang QW, Liu CY, Fan ST, Wang Y. Noninvasive model based on liver and spleen stiffness for predicting clinical decompensation in patients with cirrhosis. World J Gastroenterol 2025; 31(33): 107408
12
"This is a timely, comprehensive, and clinically valuable systematic review of photon-counting CT in oncologic imaging. The manuscript ..."  [Read more]
"This is a timely, comprehensive, and clinically valuable systematic review of photon-counting CT in oncologic imaging. The manuscript successfully synthesizes evidence across multiple cancer types and highlights both opportunities and limitations of this emerging technology. Major revisions suggested: Add a tabular summary of included studies with key characteristics. Clarify methodological limitations (lack of risk-of-bias assessment, single database). Explicitly state that ethical approval was not required. Minor revisions suggested: Streamline language in highly technical sections. Expand limitations regarding cost, accessibility, and inter-institutional standardization."  [Collapse]
Perera Molligoda Arachchige AS, Dashiell A, Jesuraj AS, D’Urso AI, Fiore B, Cattaneo M, Pierzynska E, Szydelko S, Centini FR, Verma Y. Applications of photon-counting CT in oncologic imaging: A systematic review. World J Radiol 2025; 17(8): 107732
13
"The manuscript is well-structured, comprehensive, and provides clinically relevant insights that will be highly valuable for both ..."  [Read more]
"The manuscript is well-structured, comprehensive, and provides clinically relevant insights that will be highly valuable for both radiologists and clinicians involved in the diagnosis and management of diverticulitis. The content is organized logically, covering epidemiology, classification systems, imaging findings, complications, and emerging directions such as artificial intelligence. The language is generally clear and precise, making the article accessible to its intended audience. Minor revisions are recommended to further strengthen the paper. Specifically, polishing a few sentences for clarity and conciseness would enhance readability. Since the manuscript is a review and does not involve direct patient data or interventions, it would be appropriate to explicitly state that ethical approval was not required, in order to meet standard publishing practices. In addition, the discussion could be expanded to address potential caveats or limitations, such as interobserver variability in CT interpretation, the ongoing debate regarding conservative versus surgical management, and the challenges in differentiating diverticulitis from malignancy in certain cases. Addressing these points will improve the balance of the manuscript and provide readers with a more nuanced understanding of the topic."  [Collapse]
Simsar M, Yuruk YY, Sahin O, Sahin H. Radiological insights into diverticulitis: Clinical manifestations, complications, and differential diagnosis. World J Radiol 2025; 17(8): 107463
14
"The advent of machine learning has revolutionized gastrointestinal endoscopy. However, many challenges remain to be overcome before ..."  [Read more]
"The advent of machine learning has revolutionized gastrointestinal endoscopy. However, many challenges remain to be overcome before its clinical application, including data dilemmas, algorithm complexity, and ethical dilemmas. Further technological innovation and standardization of endoscopic image data are expected to enable AI to perform everything from diagnosis to personalized treatment, across all endoscope manufacturers."  [Collapse]
Ding JC, Zhang J. Endoscopic image analysis assisted by machine learning: Algorithmic advancements and clinical uses. Artif Intell Gastrointest Endosc 2025; 6(3): 108281
15
"Objectivity The article demonstrates strong objectivity by adopting a balanced "current status-issues" framework, without one-sidedly ..."  [Read more]
"Objectivity The article demonstrates strong objectivity by adopting a balanced "current status-issues" framework, without one-sidedly overstating research progress on glioblastoma multiforme (GBM). It systematically outlines the application value of imaging technologies such as MRI (with T1-weighted contrast enhancement for visualizing tumor necrosis) and PET (with 18F-FET for distinguishing recurrence from radiation necrosis), while also clearly pointing out limitations like the poor soft tissue contrast of CT and the need for a nearby cyclotron for 11C-methylmethionine (11C-MET). When elaborating on the standard "surgery + radiotherapy + temozolomide (TMZ)" regimen, it simultaneously highlights the therapeutic bottleneck that the 5-year survival rate remains only 4.6%-5.6%. Literature screening covers multiple databases including MEDLINE, with studies up to February 2025 included in accordance with PRISMA guidelines, avoiding selective inclusion of positive results. It also maintains a neutral stance when discussing controversies in AI applications (e.g., low proficiency of doctors in operating AI tools) and does not shy away from technical flaws. Credibility The credibility is constrained by the peer review results (with scientific quality, innovation, and other indicators all rated Grade D), but there are still supporting elements. The authors are affiliated with the Department of Medical Imaging and Radiation Sciences, University of Sherbrooke, Canada; the corresponding author is a professor and contact information is provided. Literature citations are standardized, including DOI and PMID, and Tables 1-3 clearly summarize key data such as imaging tracers and chemotherapeutic drugs, with a reproducible PRISMA process. However, the single-blind review (involving only one expert from Japan) may lead to a limited perspective, and the article does not mention data replication and verification, which weakens part of its credibility. Scientific Quality As a review article, its scientific quality is moderate. Its strengths lie in a clear structure, progressing logically from "epidemiology-imaging-treatment-AI," with each conclusion supported by literature (e.g., citing Zheng et al.’s AI study using 40 million samples). It also compares the advantages and disadvantages of different imaging modalities and treatment regimens, providing references for clinical practice. Nevertheless, there are shortcomings: it fails to quantify key indicators (such as AI segmentation accuracy), describes research data on emerging nanodrugs and PARP inhibitors in a vague manner, and does not analyze diagnostic and therapeutic differences among different molecular subtypes (e.g., IDH-mutant GBM), resulting in insufficient scientific depth. Resolved Issues The article clarifies regional differences in GBM epidemiology, applicable scenarios of mainstream imaging and treatment regimens, and constructs an application framework for AI in GBM, providing systematic knowledge for beginners. It also identifies core bottlenecks such as the blood-brain barrier and difficulties in early detection, defining the research scope. Unresolved and Existing Issues It does not propose specific biomarkers for early detection (e.g., circulating tumor cells), fails to quantify data on the generalizability of AI models, provides ambiguous solutions for multi-center collaboration and data privacy protection, and does not discuss personalized diagnosis and treatment strategies for different molecular subtypes. Future Solutions The authors mention that future efforts should focus on strengthening structured validation and ethical oversight of AI. Specifically, multi-center collaboration can be conducted to establish a standardized imaging database and carry out prospective AI trials; subtype-specific treatment models can be developed by integrating genomic data; and early screening schemes combining "AI + biomarkers" can be explored to fill current research gaps."  [Collapse]
Bentourkia M, Abdo RA. Updates on glioblastoma multiforme: From epidemiology to imaging and artificial intelligence. Artif Intell Med Imaging 2025; 6(2): 108032
16
"Objectivity: The article avoids bias by balancing AI’s strengths and limitations. It details AI’s value (e.g., 3D vascular mapping ..."  [Read more]
"Objectivity: The article avoids bias by balancing AI’s strengths and limitations. It details AI’s value (e.g., 3D vascular mapping cutting DIEP flap surgery time, AR navigation improving osteotomy accuracy) while explicitly noting barriers like data variability and surgeon unfamiliarity. Literature selection follows PRISMA, retrieves 4 databases up to Feb 2025, and is PROSPERO-registered (CRD420251008741), with no selective inclusion of positive results. Credibility: Backed by external single-blind peer review (experts from China, Saudi Arabia, Türkiye) with specific gradings (scientific quality mostly Grade B, novelty Grade A-C). Authors (e.g., Harvard-affiliated Ryan P Cauley) have authoritative backgrounds; citations include DOI/PMID, and the PRISMA flow diagram (104 screened, 64 excluded, 27 included) ensures reproducibility. Scientific Quality: As a narrative review, it integrates systematic review elements (pre-registration, standardized retrieval). Results are structured by clinical scenarios (preoperative planning, etc.), each supported by studies (e.g., Le et al.’s 2023 deep learning research). The discussion links technical flaws to clinical risks (e.g., sensor inaccuracy causing missed flap ischemia) and compares AI maturity across fields. Resolved Issues: Clarified AI’s application scope in plastic surgery imaging, established a framework for analyzing AI challenges, and set methodological benchmarks for similar reviews via PRISMA/PROSPERO compliance. Unresolved Issues: Lacks quantification of data variability, cross-population model validation, plastic surgery-specific AI regulatory paths, and details on surgeon AI training. Also has potential peer-review bias, imbalanced literature timeliness, and insufficient ethical/technical transparency. Proposed Solutions: The author implies future focus on structured validation and ethical oversight. To address gaps, multi-center standardized databases, collaboration with regulators for tailored frameworks, surgeon training programs, and supplementary technical/ethical materials are needed."  [Collapse]
Yamin MA, Raquepo TM, Tobin M, Posso AN, Cauley RP. Applications and challenges of artificial intelligence in plastic surgery imaging: A narrative review. Artif Intell Med Imaging 2025; 6(2): 108028
17
"The mini-review addresses the multifunctional roles of the CD47/SIRPα pathway, emphasizing its implications in immunity, homeostasis, ..."  [Read more]
"The mini-review addresses the multifunctional roles of the CD47/SIRPα pathway, emphasizing its implications in immunity, homeostasis, and cancer therapeutics. The subject is highly relevant to biomedical research and clinical translation, and the manuscript provides an extensive overview of molecular mechanisms, cellular functions, and therapeutic strategies. The article is timely, given the increasing interest in immune checkpoint modulation and anti-CD47 therapies. The review is well structured, with clear sections covering molecular mechanisms, cellular functions, and clinical implications. The inclusion of schematic figures and summary tables is helpful, though some illustrations could be improved in resolution and annotation to make complex signaling pathways easier to follow. The manuscript successfully integrates both classical and recent literature, including clinical trial data, which strengthens its scientific significance. The references are numerous, updated, and appropriate, reflecting a good command of the field. However, the methodology for literature selection is not described, and this reduces transparency compared to systematic approaches. The language is generally clear and concise, with good readability, although a few sentences could be shortened to improve flow. The main caveat is that the article tends to be descriptive rather than analytical. In some sections, especially those on therapeutic implications, the review could benefit from a more critical discussion of controversies, limitations, and unresolved challenges, such as on-target toxicity and resistance mechanisms. Explicitly highlighting knowledge gaps would enhance the review’s impact. Overall, this is a well-prepared review on a clinically relevant topic. It effectively summarizes the multifunctional roles of CD47/SIRPα and provides a useful resource for readers. With minor revisions to strengthen the critical analysis and presentation of figures, the manuscript is suitable for publication and may attract significant interest from the field."  [Collapse]
Bhardwaj N, Chandra H, Singh A, Babu R. CD47/SIRPα pathways: Functional diversity and molecular mechanisms. World J Biol Chem 2025; 16(3): 108045
18
"The manuscript presents a comprehensive metabolomic analysis of Gardenia jasminoides fruits collected from different provenances in ..."  [Read more]
"The manuscript presents a comprehensive metabolomic analysis of Gardenia jasminoides fruits collected from different provenances in Hunan Province, China. The topic is relevant to natural product chemistry and pharmacognosy, and the use of UHPLC-MS/MS combined with antioxidant assays adds methodological strength. The description of the experimental setup is detailed and generally sufficient to allow reproducibility, which is a positive aspect. The results are well-supported by data, including PCA, HCA, and correlation analyses, and the conclusions appear consistent with the findings. The figures and tables are informative and mostly well-designed, although some chromatograms and heatmaps could benefit from improved labelling and clarity for international readers. The statistical approaches are appropriate, with adequate use of replicates and validation steps. The interpretation of antioxidant assays is clear, although the biological significance could be expanded beyond correlations with geniposide, crocin, and chlorogenic acid. The references are adequate but somewhat regionally focused. Including more international comparative studies on plant metabolomics and bioactivity would increase the article’s global relevance. The language is acceptable overall, but there are occasional grammatical issues and awkward expressions that could be improved by careful editing. Limitations include the fact that only one geographic region was sampled, which may limit generalizability. Moreover, the study is restricted to antioxidant capacity without further validation of pharmacological activity. Addressing these limitations in the discussion would strengthen the article. In conclusion, this is a valuable contribution to the metabolomics characterization of medicinal plants, with solid methodology and reliable results, though with moderate impact due to its regional scope. The manuscript is suitable for publication after minor language polishing and some improvement in discussion of broader implications."  [Collapse]
Bi WY, He WL, Wang W, Wang XR, Zhou ZJ, Zeng YL. Chemical composition differences in wild Gardenia jasminoides fruits across provenances using metabolomics. World J Biol Chem 2025; 16(3): 105875
19
"Thank you for pointing to the some key issues remaining unresolved till now in this area of research. Standard clinical trials, a ..."  [Read more]
"Thank you for pointing to the some key issues remaining unresolved till now in this area of research. Standard clinical trials, a more holistic approach, including epigenetics, the assessment of genetic association analyses are necessary for a thorough understanding of potential pitfalls, including ethnic and/or even cultural differences. Sand PG, Poeppl TB, Roessler V. Unmet needs in precision psychiatry. World J Psychiatry 2025; 15(9): 108222 [DOI: 10.5498/wjp.v15.i9.108222] "  [Collapse]
Sand PG, Poeppl TB, Roessler V. Unmet needs in precision psychiatry. World J Psychiatry 2025; 15(9): 108222
20
"Dear authors, thank you for this article, it points to a very important topic to open up mentalization based interventions or ..."  [Read more]
"Dear authors, thank you for this article, it points to a very important topic to open up mentalization based interventions or mindfulness-based stress reduction. Emotional awareness and nonjudgmental present-moment awareness to foster adaptive coping strategies is a very promising parameter for professionals. Further research is very much needed, thank you for opening up this topic in your review. Zhou RR, Chen LL, Lin LD. Mindfulness-based stress reduction and mental health in department of emergency nurses: A narrative review. World J Psychiatry 2025; 15(9): 107630 [DOI: 10.5498/wjp.v15.i9.107630]"  [Collapse]
Zhou RR, Chen LL, Lin LD. Mindfulness-based stress reduction and mental health in department of emergency nurses: A narrative review. World J Psychiatry 2025; 15(9): 107630
15792 items  Read more >>
Peer-Reviewers and Manuscript Statistics
Editorial board members
2264
Peer-reviewers
33598
Manuscripts received today
27
Manuscript reviews today
51
Unhandled manuscripts today
140
Active peer-reviewers today
2158
Reviewer acceptance today
78
Reviewer refusals today
83
Total accepted manuscripts
37725
Total rejected manuscripts
43027
Total peer-reviewers
4370656
Total submissions
35853
Baishideng Publishing Group (BPG) publishes 47 peer-reviewed, open-access journals covering a broad range of topics in clinical medicine, as well as several topics in biochemistry and molecular biology, relevant to human health today.
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Read more >>
Sign In
  • BPG Management System
  • F6Publishing-Submit a Manuscript
  • F6Publishing-世界华人消化杂志在线投稿
  • RCA Management System
English
  • English
  • 简体中文
BPG Journals
Reference Citation Analysis
  • Find an Article (56960021)
  • Find an Article PDF (5404646)
  • Today's Articles (153)
  • Find a Category (125)
  • Find a Journal (7894)
  • Find a Scholar (4390)
  • Find an Academic Assistant (52)
  • Subscribe (53764)
BPG E-Books
BPG Blog
All Journal Articles
1

Liau JYJ, Shelat VG. Evolving ethos of medical research: A retrospective analysis of the declaration of Helsinki (1964-2024). World J Methodol 2025; 15(4): 107699

2025-12-20 | Browse: 4679 | Download: 203
2

English K, Uwibambe C, Daniels P, Dzukey E. Scoping review of micronutrient imbalances, clinical manifestations, and interventions. World J Methodol 2025; 15(4): 107664

2025-12-20 | Browse: 5091 | Download: 358
3

Hafez MM, Bahcecioglu IH, Yalniz M, Kouta KA, Tawheed A. Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines. World J Methodol 2025; 15(4): 107643

2025-12-20 | Browse: 5689 | Download: 300
4

Hu HF. Research on the high quality innovative development model of "Chain + virtual elderly care" services in Hengyang city based. World J Methodol 2025; 15(4): 107503

2025-12-20 | Browse: 4115 | Download: 222
5

Vempati R, Damarlapally N, Vasudevan SS, Patel V, Banda P, Mourad D, Polamarasetty H, Mathur G, Khan A, Desai R, Ratnani I, Surani S. Association of neutrophil-lymphocyte ratio with cardiovascular and all-cause mortality in patients receiving chronic hemodialysis: Systematic review and meta-analysis. World J Methodol 2025; 15(4): 107468

2025-12-20 | Browse: 4730 | Download: 258
6

Abdulrasak M, Ahmed M, Hootak S. Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review. World J Methodol 2025; 15(4): 107411

2025-12-20 | Browse: 4444 | Download: 233
7

Okasha HH, Gadour E, Alyouzbaki AZ, Shaaban HE. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors: Current status and future perspectives. World J Methodol 2025; 15(4): 107305

2025-12-20 | Browse: 5068 | Download: 232
8

Kaur R, Morya AK, Gupta PC, Aggarwal S, Menia NK, Kaur A, Kaur S, Sinha S. Artificial intelligence-based apps for screening and diagnosing diabetic retinopathy and common ocular disorders. World J Methodol 2025; 15(4): 107166

2025-12-20 | Browse: 5178 | Download: 306
9

Metin İ, Özdemir Ö. Artificial intelligence in medicine: Current applications in cardiology, oncology and radiology: A mini review. World J Methodol 2025; 15(4): 106854

2025-12-20 | Browse: 4730 | Download: 266
10

Lucero CM, Luco JB, Albani Forneris A, Buttaro MA. Recurrent femoral stem fractures in Dorr A femurs: Lessons learned and a call for alternative strategies. World J Methodol 2025; 15(4): 106708

2025-12-20 | Browse: 3987 | Download: 217
11

Solstad TU, Mucha AW, Olsen AA, Grossjohann H, Achiam MP. Preoperative marking of the proximal resection margin in esophageal cancer with a surgical fiducial marker-first experiences. World J Methodol 2025; 15(4): 106591

2025-12-20 | Browse: 4503 | Download: 314
12

Stamiris S, Cheva A, Potoupnis M, Anestiadou E, Stamiris D, Bekiari C, Loukousia A, Kyriakos P, Tsiridis E, Sarris I. Effect of alpha-tocopherol and OTR-4131 on muscle degeneration after rotator cuff tear in rats: An experimental protocol. World J Methodol 2025; 15(4): 106216

2025-12-20 | Browse: 4173 | Download: 283
13

Singh JP, Aleissa M, Chitragari G, Drelichman ER, Mittal VK, Bhullar JS. Uncovering the role of microbiota and fecal microbiota transplantation in Crohn’s disease: Current advances and future hurdles. World J Methodol 2025; 15(4): 106148

2025-12-20 | Browse: 4294 | Download: 229
14

Xu DJ, Zhong Q, Wang GT, Lu X. Preventive and therapeutic effects of magnesium sulfate on nikethamide-induced seizures: Implications for COVID-19 treatment. World J Methodol 2025; 15(4): 105775

2025-12-20 | Browse: 4619 | Download: 287
15

Das N, Gade KR, Addanki PK. Artificial intelligence for early diagnosis and risk prediction of periodontal-systemic interactions: Clinical utility and future directions. World J Methodol 2025; 15(4): 105516

2025-12-20 | Browse: 4743 | Download: 271
16

Musbahi O, Pouris K, Hadjixenophontos S, Al-Saadawi A, Soteriou I, Cobb JP, Jones GG. Machine learning for patient selection in corticosteroid decision making in knee osteoarthritis: A feasibility model. World J Methodol 2025; 15(4): 105493

2025-12-20 | Browse: 4383 | Download: 334
17

Kamrul-Hasan ABM, Pappachan JM, Ashraf H, Nagendra L, Dutta D, Kuchay MS, Shaikh S. Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis. World J Methodol 2025; 15(4): 105478

2025-12-20 | Browse: 4777 | Download: 285
18

Cigrovski Berkovic M, Cigrovski V, Ruzic L. Role of irisin in physical activity, sarcopenia-associated type 2 diabetes, and cardiovascular complications. World J Methodol 2025; 15(4): 105462

2025-12-20 | Browse: 4286 | Download: 266
19

Jain A, Kaushal A, Kumar H, Karna ST, Ahmad Z, Trivedi S. Analgesic efficacy of continuous ultrasound-guided unilateral erector-spinae block and thoracic epidural in patients undergoing antero-lateral thoracotomy. World J Methodol 2025; 15(4): 105386

2025-12-20 | Browse: 4397 | Download: 261
20

Ardila CM. Advancing dental precision: The synergy of magnification and artificial intelligence. World J Methodol 2025; 15(4): 105326

2025-12-20 | Browse: 3935 | Download: 211
60069 items  Read more >>
Featured Articles
1

Nguyen JT, Anand M. Avacopan in the treatment of relapsing polychondritis with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis: A case report. World J Nephrol 2025; 14(3): 109400

2025-09-17 | Browse: 38 | Download: 12
2

Khalid A, Yakubu KB, Umar AM, Aljannare BG, Aminu NA, Obadele OG, Abdulwahab-Ahmed A. Uncommon presentation and management of a giant renal cyst abscess: A case report. World J Nephrol 2025; 14(3): 108703

2025-09-17 | Browse: 37 | Download: 13
3

Elahi T, Mubarak M, Ahmed S, Narejo FR. Global emergence of the chikungunya epidemic: A narrative review of the virus-kidney relationship in Pakistan and beyond. World J Nephrol 2025; 14(3): 107415

2025-09-17 | Browse: 29 | Download: 11
4

Gembillo G, Peritore L, Spadaro G, Cuzzola F, Calderone M, Messina R, Di Piazza S, Sudano F, Gambuzza ME, Princiotto M, Soraci L, Santoro D. Kidney involvement and anemia in COVID-19 infection. World J Nephrol 2025; 14(3): 107582

2025-09-17 | Browse: 36 | Download: 11
5

Govindarajan KK. Variation coefficient of stone density – can it crack the stone? World J Nephrol 2025; 14(3): 101469

2025-09-17 | Browse: 35 | Download: 12
6

Khan SMI, Asif H, Raza MH, Waqas M, Ali SZ, Khawar M, Saifullah M, Mehdi AM. Trends and disparities in mortality from comorbid non-insulin-dependent diabetes mellitus and stroke (1999–2022): A retrospective analysis. World J Neurol 2025; 11(1): 110105

2025-09-17 | Browse: 35 | Download: 15
7

Gundareddy V, Singla S, Mounika J, Owona O, Singla B, Singh T, Anwar S, Ramachandran V, Ullah H, Mazari S. Coronary computed tomography angiography versus stress testing for stable angina evaluation: Diagnostic and prognostic superiority. World J Cardiol 2025; 17(9): 110061

2025-09-17 | Browse: 36 | Download: 0
8

Kar S, Espinoza C. Gender-based radiation exposure and clinical outcomes in peripheral endovascular intervention for limb ischemia: A prospective study. World J Cardiol 2025; 17(9): 110220

2025-09-17 | Browse: 42 | Download: 0
9

Xu JX, Wu Y, Zhang L, Wu YH, Li CL, Lin F. Correlation of APOE, SLCO1B1 and LPA KIV-2 gene polymorphisms with coronary heart disease in the Teochew population. World J Cardiol 2025; 17(9): 110278

2025-09-17 | Browse: 44 | Download: 0
10

Santoso RM, Huang W, Wee S, Siswanto BB, Soesanto AM, Jatmiko W, Kekalih A. Streamlining heart failure patient care with machine learning of thoracic cavity sound data. World J Cardiol 2025; 17(9): 109992

2025-09-17 | Browse: 42 | Download: 0
11

Koros R, Domouzoglou EM, Papafaklis MI. Metabolically "healthy" obesity in postmenopausal women: Unmasking the cardiovascular risk. World J Cardiol 2025; 17(9): 110228

2025-09-17 | Browse: 38 | Download: 0
12

Bu HY, Huang H, Li J, Huang ZB, Huang Y, Huang YK, Wang AM, Wu L, Yuan J, Wang RJ, Lu M, Yu SM, Yi PP, Chen YY, Jiang YP, Hu XW. Methionyl-tRNA synthetase 1 participates in hepatocellular carcinoma and its regulated gene profile possesses potent prognostic ability. World J Gastrointest Oncol 2025; 17(9): 109127

2025-09-15 | Browse: 212 | Download: 79
13

Qiu ZS, Wang XC, Ma JC, Zhu CL, Hu YL, Da MX. DEAD/H-box RNA helicase 10 promotes pancreatic cancer cell proliferation via ribonucleotide reductase M2. World J Gastrointest Oncol 2025; 17(9): 108672

2025-09-15 | Browse: 191 | Download: 45
14

Huang JW, Lin C, Lu CJ, Wang HS, Zou DD. Serum gastrin and Helicobacter pylori infection correlate with tumor aggressiveness and prognosis in gastric cancer. World J Gastrointest Oncol 2025; 17(9): 110981

2025-09-15 | Browse: 212 | Download: 78
15

Kim S, Kim N, Lee HS, Kim M, Kim H, Choi Y. Medical travel patterns for hepatocellular carcinoma treatment in South Korea: National Health Insurance data from 2013 to 2021. World J Gastrointest Oncol 2025; 17(9): 109060

2025-09-15 | Browse: 211 | Download: 80
16

Christodoulidis G, Bartzi D, Tsagkidou K, Koumarelas KE, Zacharoulis D. Status quo of hypercoagulation as a prognostic indicator following neoadjuvant immunochemotherapy in locally advanced gastric cancer. World J Gastrointest Oncol 2025; 17(9): 106868

2025-09-15 | Browse: 193 | Download: 62
17

Lubbad O, Mahmood WU, Shafique S, Singh KK, Khera G, Sajid MS. Effect of prehabilitation in patients undergoing hepatobiliary and pancreatic cancer resections: A systematic review and meta-analysis. World J Gastrointest Endosc 2025; 17(9): 109029

2025-09-12 | Browse: 417 | Download: 71
18

Belimezakis N, Gianni P, Geropoulos G, Giannis D. Peroral endoscopic myotomy in children with achalasia: A review of the literature. World J Gastrointest Endosc 2025; 17(9): 108639

2025-09-12 | Browse: 421 | Download: 63
19

Castleberry DT, Mann R, Tharian B, Thandassery RB. Endoscopic ultrasound in the management of complications related to cirrhosis- recent evidence. World J Gastrointest Endosc 2025; 17(9): 108549

2025-09-12 | Browse: 399 | Download: 64
20

Zhang M, Liu J, Gu JN, Han K, Jia W, Li P, Sun Y, An N, Yang Z. Advances in endoscopic closure techniques for endoscopic full-thickness resection. World J Gastrointest Endosc 2025; 17(9): 107157

2025-09-12 | Browse: 408 | Download: 71
9904 items  Read more >>
Keyword Search Published Articles Processes
1
Case report
2853
2
Case report
1742
3
Hepatocellular carcinoma
1448
4
Gastric cancer
1022
5
Colorectal cancer
1000
6
Inflammatory bowel disease
722
7
COVID-19
707
8
Prognosis
671
9
Liver transplantation
621
10
Ulcerative colitis
557
11
Treatment
552
12
Helicobacter pylori
521
13
Crohn’s disease
517
14
Diagnosis
517
15
Endoscopy
480
16
Cirrhosis
479
17
Meta-analysis
454
18
Pancreatic cancer
447
19
Magnetic resonance imaging
440
20
Surgery
423
71794 items  Read more >>
Reader Comments
1
"Inhibition of Hippo/YAP signaling pathways by levodopa as novel therapeutic approaches for liver fibrosis. Jin-Bo Zhao1*, Gu-Qing ..."  [Read more]
"Inhibition of Hippo/YAP signaling pathways by levodopa as novel therapeutic approaches for liver fibrosis. Jin-Bo Zhao1*, Gu-Qing Luo1*, Jia-Yun Lin1, Chi-Hao Zhang1, Guang-Bo Wu1, Hongjie Li1,Meng Luo1, Zheng-Hao Wu1#, Lei Zheng1# 1Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. *, # equal contribution. Abstract This commentary discusses a recently published article in the World Journal of Gastroenterology. Using a rat model of liver fibrosis induced by CCl4 Injection, the article confirms that Dopamine receptor D1 (DRD1) is closely associated with liver injury and the progression of liver fibrosis. To verify that the interaction between this receptor and the Yes-associated protein 1 (YAP1) signaling pathway plays a critical role in liver fibrosis, levodopa was administered in the CCl4 rat model to activate DRD1, which in turn inhibited the nuclear translocation of YAP1 protein. In previous studies, YAP1 has been shown to exert important functions in the process of liver injury repair. Therefore, the findings of this study demonstrate the interaction between DRD1, activated by levodopa treatment and the YAP1 signaling pathway, thereby providing evidence from animal experiments to support levodopa as a novel therapeutic strategy for liver fibrosis. Key Words: Dopamine receptor D1; Liver fibrosis; Yes-associated protein 1, CCl4 rat model, G protein-coupled receptors Core Tip: Based on the results of previous studies and preliminary experiments, this manuscript confirms a close association between the activation of DRD1 and the YAP1 signaling pathway. Notably, the nuclear translocation of YAP1 is a key mechanism for YAP1 to exert its biological functions. Activation of DRD1 by levodopa inhibits the nuclear translocation of YAP1, thereby alleviating liver injury and retarding the progression of liver fibrosis. TO THE EDITOR G protein-coupled receptors (GPCRs) constitute the largest family of membrane receptors encoded by the human genome and stand out as highly productive therapeutic targets—ligands targeting GPCRs represent over 30% of all clinically approved medications[1]. For fibrotic disorders, researchers have explored both GPCR inhibitors[2-5] and activators[6-8] to evaluate their therapeutic potential. Functionally, GPCRs interact with effector proteins associated with four major classes of G-proteins. Recent studies have clarified a key functional distinction: activation of GPCRs coupled to Gα12/13, Gαq/11, or Gαi/o subtypes promotes the nuclear translocation and transcriptional activity of YAP/TAZ; by contrast, GPCRs that couple to Gαs suppress YAP/TAZ nuclear localization and functional activity through increasing cyclic adenosine monophosphate (cAMP) levels[9]. Critically, GPCR expression exhibits significant heterogeneity—varying not only across different organs but also among adjacent cell types within the same tissue[10]. This expression pattern opens up the possibility of developing GPCR-directed therapies as a strategy for cell-selective inhibition of YAP/TAZ. Specifically, identifying and activating a GPCR that is selectively expressed on fibroblasts could provide a targeted approach: by inhibiting YAP/TAZ within the activated fibroblasts that drive disease progression, such a strategy could counteract multiple pro-fibrotic stimuli simultaneously. In the present study, researchers identified the dopamine receptor DRD1 as a fibroblast-selective target. When activated (via agonism), DRD1 inhibits YAP/TAZ-mediated fibroblast activation, reduces extracellular matrix (ECM) deposition and stiffening, and ultimately reverses experimental liver fibrosis. Biologically, DRD1 exhibits selective coupling to Gαs, a interaction that drives cAMP elevation[11]. This coupling enables DRD1 to counteract both mechanical and biochemical pro-fibrotic signals that otherwise promote fibroblast activation. Functionally, this translates to a key phenotypic shift in fibroblasts: DRD1 agonism effectively converts fibroblasts from a state that supports ECM deposition and tissue stiffening to one that favors ECM degradation and tissue softening. Against this research background, the administration of levodopa in CCl₄ rat model effectively activated DRD1, which was followed by the inhibition of YAP1 nuclear translocation. This sequence of events significantly suppressed the role of YAP1 in the progression of liver fibrosis. This promising finding provides an opportunity for the clinical application of this therapeutic target. MAIN FINDINGS OF THIS STUDY In this study, the administration of levodopa in CCl₄-induced rat model initially demonstrated alleviation of liver injury and liver fibrosis. Meanwhile, by reducing the dose of levodopa, the severe side effects of levodopa in the rat model treatment were partially avoided. Subsequently, experimental assays confirmed the significant activation of DRD1 and the inhibition of YAP1. Furthermore, through the detection of phosphorylated YAP1 (p-YAP1), the study elaborated on the detailed mechanism underlying the inhibition of the YAP1 signaling pathway. Combining the experimental results with the basic insights from previous studies, and by detailing the protein signaling pathway mechanism, this research revealed the critical mechanism of DRD1 activation in the progression of liver fibrosis. THE LIMITATIONS OF THIS STUDY The findings of this study are limited to CCl₄-induced rat model, which cannot fully encompass the comprehensive pathogenesis of liver fibrosis and cirrhosis[12-14]. Therefore, further studies using other models and human samples are required to validate the therapeutic role of DRD1 in the progression of liver fibrosis. Moreover, the expression of YAP1 exhibits cellular heterogeneity in the liver: YAP1 is expressed at non-negligible levels in cholangiocytes[15], endothelial cells, and hepatocytes, where it exerts critical functions, and changes in its expression during disease have also been extensively investigated. Notably, the functions and mechanisms of YAP1 in different cell types correspond to distinct pathological phenotypes, thereby exerting diverse physiological effects on the progression of liver fibrosis[16]. Furthermore, in studies on the role of the YAP1 protein in liver fibrosis, researchers have used verteporfin and metformin to inhibit the intrahepatic fibrotic process. Meanwhile, at the cellular level, in-depth investigations have been conducted into the function of the YAP1 protein in cholangiocytes and hepatic stellate cells[17]. Therefore, in future research, the cell type-specific localization of functionally active DRD1 should be precisely identified, which will facilitate a more accurate understanding of the therapeutic target responsible for its anti-fibrotic effects. CLINICAL SIGNIFICANCE OF THIS STUDY Despite the limitations, this study still holds significant clinical implications: Using levodopa (a DRD1 agonist), the researchers demonstrated that activation of this receptor in the liver and inhibition of YAP1 nuclear translocation could be achieved. Based on previous studies investigating the mechanism of YAP1 action in various liver cell types, YAP1 has been shown to accelerate the development and progression of liver diseases[16]. Although this study failed to specifically target and inhibit YAP1 function in a single specific liver cell type, comprehensive inhibition of intrahepatic YAP1 function may effectively alleviate disease progression. Collectively, these findings provide a potential and effective therapeutic target for the clinical treatment of liver fibrosis. CONCLUSION Currently, the mechanism by which DRD1 activation improves liver function in patients with chronic liver disease and liver fibrosis remains insufficiently understood. In-depth exploration of this underlying mechanism will provide a new direction for the clinical translation of DRD1 activation strategies. Furthermore, conducting clinical studies to evaluate the safety of DRD1 activation for liver fibrosis treatment, standardizing the manufacturing process of DRD1 agonists, and developing novel DRD1 activators will offer evidence to validate the clinical application of DRD1-based therapies. CONTRIBUTOR INFORMATION Jin-Bo Zhao,Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Gu-Qing Luo,Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Jia-Yun Lin,Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Chi-Hao Zhang,Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Guang-Bo Wu,Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hongjie Li,Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Meng Luo, Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Zheng-Hao Wu,Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Lei Zheng,Department of General Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.zl1055174020@163.com REFERENCES 1 Hauser AS, Attwood MM, Rask-Andersen M, Schiöth HB, Gloriam DE. Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov. 2017. 16(12): 829-842. 2 Swigris JJ, Brown KK. The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis. BioDrugs 2010; 24: 49-54 [PMID: 20055532 DOI: 10.2165/11319550-000000000-00000] 3 Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 2008; 14: 45-54 [PMID: 18066075 DOI: 10.1038/nm1685] 4 Ikeda H, Yatomi Y. Autotaxin in liver fibrosis. Clin Chim Acta 2012; 413: 1817-1821 [PMID: 22820036 DOI: 10.1016/j.cca.2012.07.014] 5 Rodríguez-Pascual F, Busnadiego O, González-Santamaría J. The profibrotic role of endothelin-1: is the door still open for the treatment of fibrotic diseases. Life Sci 2014; 118: 156-164 [PMID: 24378671 DOI: 10.1016/j.lfs.2013.12.024] 6 Polat B, Halici Z, Cadirci E, Karakus E, Bayir Y, Albayrak A, Unal D. Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro. Int Immunopharmacol 2017; 43: 227-235 [PMID: 28043031 DOI: 10.1016/j.intimp.2016.12.023] 7 McBride A, Hoy AM, Bamford MJ, Mossakowska DE, Ruediger MP, Griggs J, Desai S, Simpson K, Caballero-Hernandez I, Iredale JP, Pell T, Aucott RL, Holmes DS, Webster SP, Fallowfield JA. In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis. Sci Rep 2017; 7: 10806 [PMID: 28883402 DOI: 10.1038/s41598-017-10521-9] 8 Huang S, Wettlaufer SH, Hogaboam C, Aronoff DM, Peters-Golden M. Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol 2007; 292: L405-413 [PMID: 17028262 DOI: 10.1152/ajplung.00232.2006] 9 Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, Fu XD, Mills GB, Guan KL. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012; 150: 780-791 [PMID: 22863277 DOI: 10.1016/j.cell.2012.06.037] 10 Insel PA, Snead A, Murray F, Zhang L, Yokouchi H, Katakia T, Kwon O, Dimucci D, Wilderman A. GPCR expression in tissues and cells: are the optimal receptors being used as drug targets. Br J Pharmacol 2012; 165: 1613-1616 [PMID: 21488863 DOI: 10.1111/j.1476-5381.2011.01434.x] 11 Flock T, Hauser AS, Lund N, Gloriam DE, Balaji S, Babu MM. Selectivity determinants of GPCR-G-protein binding. Nature 2017; 545: 317-322 [PMID: 28489817 DOI: 10.1038/nature22070] 12 Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: Pathophysiology and clinical implications. WIREs Mech Dis 2021; 13: e1499 [PMID: 32713091 DOI: 10.1002/wsbm.1499] 13 Kannt A, Wohlfart P, Madsen AN, Veidal SS, Feigh M, Schmoll D. Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis. Br J Pharmacol 2021; 178: 2412-2423 [PMID: 33655500 DOI: 10.1111/bph.15427] 14 Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int 2018; 12: 1-10 [PMID: 29064029 DOI: 10.1007/s12072-017-9827-9] 15 Zhang J, Lyu Z, Li B, You Z, Cui N, Li Y, Li Y, Huang B, Chen R, Chen Y, Peng Y, Fang J, Wang Q, Miao Q, Tang R, Gershwin ME, Lian M, Xiao X, Ma X. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases. Hepatology 2023; 78: 10-25 [PMID: 36799463 DOI: 10.1097/HEP.0000000000000317] 16 Lee NY, Choi MG, Lee EJ, Koo JH. Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression. Arch Pharm Res 2024; 47: 558-570 [PMID: 38874747 DOI: 10.1007/s12272-024-01501-5] 17 Ye L, Ziesch A, Schneider JS, Ofner A, Nieß H, Denk G, Hohenester S, Mayr D, Mahajan UM, Munker S, Khaled NB, Wimmer R, Gerbes AL, Mayerle J, He Y, Geier A, Toni EN, Zhang C, Reiter FP. The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4(-/-) Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology. Aging Dis 2024; 15: 338-356 [PMID: 37307826 DOI: 10.14336/AD.2023.0602] "  [Collapse]
Wang HY, Qi MM, Zhang K, Zhu YZ, Zhang J. Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment. World J Gastroenterol 2025; 31(34): 108617
2
"The study by Özcan and Düzgün provides valuable real-world evidence on the timing of diverting loop ileostomy closure after rectal ..."  [Read more]
"The study by Özcan and Düzgün provides valuable real-world evidence on the timing of diverting loop ileostomy closure after rectal resection. The authors show that early closure is associated with similar complication rates compared to late closure, while offering advantages such as fewer readmissions for dehydration and improved psychosocial recovery. The manuscript is clearly structured, the methods are adequately described, and the results are consistent with prior randomized controlled trials suggesting that early closure may be safe in selected patients. The main limitation is its retrospective single-center design, which introduces potential selection bias and limits long-term conclusions. Nonetheless, the findings contribute meaningful data that reinforce the need for further multicenter randomized trials. Overall, this is a timely and clinically relevant study that highlights the potential benefits of early ileostomy closure when applied selectively. "  [Collapse]
Özcan P, Düzgün Ö. Comparison of complication rates after early and late closure of loop ileostomies: A retrospective cohort study. World J Gastrointest Surg 2025; 17(8): 109432
3
"To the Editor, We read with great interest the editorial by Elshahhat and Almekoud entitled “Radial head arthroplasty: A pillar of ..."  [Read more]
"To the Editor, We read with great interest the editorial by Elshahhat and Almekoud entitled “Radial head arthroplasty: A pillar of stability in complex elbow fractures” (World J Orthop 2025;16(9):110433). The authors provide a comprehensive synthesis of the current literature on radial head arthroplasty (RHA) in Mason type III and IV fractures, emphasizing its biomechanical rationale, implant design evolution, and complication spectrum. Their analysis convincingly reinforces the notion of RHA as a cornerstone in the management of irreparable radial head fractures where elbow stability is threatened. We would like to commend the authors for highlighting the lateral column’s biomechanical role and for proposing a pragmatic treatment algorithm that can guide clinical decision-making in these challenging injuries. At the same time, we wish to offer additional perspectives and constructive critiques to further enrich the ongoing discussion. First, we strongly support the emphasis placed on the biomechanical significance of the radial head. As the authors correctly point out, the radial head acts as a secondary stabilizer to valgus stress and contributes to posterolateral rotatory stability, especially in the setting of collateral ligament insufficiency [1]. In our own clinical practice, we have observed that restoration of the radial head through arthroplasty often serves as the linchpin for achieving functional stability when addressing terrible triad injuries or fracture-dislocations [2]. However, one aspect that merits further elaboration is the interaction between implant morphology and patient-specific anatomy. Morphometric studies have shown considerable variability in radial head dimensions, offsets, and orientations [3,4], which makes the “one-size-fits-all” approach potentially problematic. While modular systems address some of these concerns, the risk of overstuffing or malalignment persists, underscoring the need for preoperative three-dimensional imaging and possibly patient-specific templating [5]. Second, we agree with the authors’ assessment that RHA has largely supplanted resection in the context of ligamentous injuries, given the deleterious consequences of proximal radial migration and valgus overload [6]. Nevertheless, the long-term durability of RHA remains an unresolved issue. Although multiple meta-analyses suggest high short- to mid-term survivorship rates [7,8], registry-level and long-term prospective studies are scarce. In younger, high-demand patients, the balance between preserving stability and risking implant-related complications is particularly delicate. The current literature is underpowered to definitively establish whether RHA provides sustained benefits in this subgroup, and this gap deserves acknowledgment. Third, we wish to expand on the discussion of prosthetic designs. The evolution from monobloc silicone implants to modular metallic and pyrocarbon systems is well outlined in the editorial [9]. However, the clinical significance of design differences is still debated. Comparative studies have reported heterogeneous outcomes, with no single design emerging as definitively superior [10,11]. This variability suggests that surgical technique, intraoperative sizing, and postoperative rehabilitation may play equally crucial roles in outcomes as prosthesis selection itself. Moreover, future directions such as three-dimensional printed implants and truly anatomic designs with variable offset and curvature hold promise in minimizing complications like capitellar erosion and overstuffing [12]. Incorporating additive manufacturing and preoperative CT-based templating could allow for more accurate replication of native radial head morphology and better restoration of kinematics. Fourth, we wish to highlight the underappreciated role of imaging and intraoperative assessment in preventing common complications. As the authors describe, overstuffing remains one of the most problematic failure modes. In addition to intraoperative fluoroscopy and reference to the lesser sigmoid notch, we advocate for routine use of preoperative CT-based planning to predict optimal head height and offset [13]. Furthermore, dynamic intraoperative assessment of forearm rotation and radiocapitellar congruence can be valuable adjuncts to radiographic evaluation in achieving correct implant positioning [14]. In terms of complication analysis, the editorial rightly emphasizes aseptic loosening, stiffness, heterotopic ossification, and overstuffing as recurring problems. We believe it is also important to contextualize these complications by differentiating between radiographic findings and clinically significant failures. For example, radiolucent lines in press-fit systems may not always herald mechanical loosening but may instead represent benign adaptive remodeling [15]. Similarly, limited stiffness may respond well to soft tissue release or rehabilitation without necessitating revision [16]. Such nuances are critical to avoid unnecessary reoperations and to optimize resource utilization. A final point relates to cost-effectiveness. The authors correctly note that upfront implant costs must be weighed against long-term revision and rehabilitation burdens. Indeed, recent database studies have suggested that RHA may be economically favorable compared to open reduction and internal fixation (ORIF) when considering reoperation rates and return-to-function timelines [17]. However, most of these analyses have been conducted in Western healthcare systems. Comparative cost-effectiveness data from low- and middle-income countries remain sparse yet are crucial to determining the global applicability of RHA as the preferred treatment [18]. In conclusion, we applaud Elshahhat and Almekoud for their timely and comprehensive editorial on the pivotal role of RHA in Mason type III and IV radial head fractures. We fully concur that RHA represents a biomechanically sound and clinically reliable solution in unreconstructible fractures, particularly when stability is compromised. At the same time, we advocate for more individualized, imaging-guided approaches, longer-term outcome studies, and exploration of emerging technologies such as three-dimensional printed implants to optimize patient outcomes. Future research should aim to stratify indications by patient age, activity level, and associated injuries, thereby refining the treatment algorithm proposed by the authors. We thank the authors for advancing the discourse on this important topic and hope our perspectives contribute to further refining the role of RHA in contemporary elbow trauma care. Sincerely, Baojian Song, MD, PhD Department of Orthopaedics, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, China  References: 1. Karbach LE, Elfar J. Elbow Instability: Anatomy, Biomechanics, Diagnostic Maneuvers, and Testing. J Hand Surg Am 2017;42:118-126. 2. Leigh WB, Ball CM. Radial head reconstruction versus replacement in the treatment of terrible triad injuries of the elbow. J Shoulder Elbow Surg 2012;21:1336-1341. 3. King GJ, Zarzour ZD, Patterson SD, Johnson JA. An anthropometric study of the radial head: implications in the design of a prosthesis. J Arthroplasty 2001;16:112-116. 4. Swieszkowski W, Skalski K, Pomianowski S, Kedzior K. The anatomic features of the radial head and their implication for prosthesis design. Clin Biomech (Bristol) 2001;16:880-887. 5. Gupta GG, Lucas G, Hahn DL. Biomechanical and computer analysis of radial head prostheses. J Shoulder Elbow Surg 1997;6:37-48. 6. Antuña SA, Sánchez-Márquez JM, Barco R. Long-term results of radial head resection following isolated radial head fractures in patients younger than forty years old. J Bone Joint Surg Am 2010;92:558-566. 7. Sun H, Duan J, Li F. Comparison between radial head arthroplasty and open reduction and internal fixation in patients with radial head fractures (modified Mason type III and IV): a meta-analysis. Eur J Orthop Surg Traumatol 2016;26:283-291. 8. De Mauro D, Chakra SA, Liuzza F, Smakaj A, Rovere G, Maccauro G, El Ezzo O. Radial head arthroplasty vs. open reduction and internal fixation in Mason III fractures: meta-analysis of prospective trials. JSES Int 2025;9:260-267. 9. Laumonerie P, Tibbo ME, Reina N, Pham TT, Bonnevialle N, Mansat P. Radial head arthroplasty: a historical perspective. Int Orthop 2019;43:1643-1651. 10. Rotini R, Marinelli A, Guerra E, et al. Radial head arthroplasty: monopolar vs. bipolar prostheses. Musculoskelet Surg 2012;96 Suppl 1:S69-S75. 11. Gramlich Y, Klug A, et al. Comparative outcomes of monopolar vs bipolar radial head arthroplasty. Arch Orthop Trauma Surg 2020;140:1025-1034. 12. Heijink A, Morrey BF, et al. Current concepts in radial head arthroplasty. J Hand Surg Am 2014;39:210-218. 13. Gauci MO, Winter M, et al. The “delta river sign” for overstuffing in radial head arthroplasty. J Shoulder Elbow Surg 2016;25:2023-2029. 14. Beingessner DM, Dunning CE, Gordon KD, Johnson JA, King GJ. The effect of radial head excision and arthroplasty on elbow kinematics and stability. J Bone Joint Surg Am 2004;86:1730-1739. 15. Rotini R, Marinelli A, Guerra E, et al. Radiographic radiolucency in radial head prostheses: clinical significance. Musculoskelet Surg 2012;96 Suppl 1:S69-S75. 16. Amaro C, et al. Management algorithm for stiffness following radial head arthroplasty. J Shoulder Elbow Surg 2018;27:1104-1112. 17. Reinhardt D, Toby EB, Brubacher J. Reoperation rates and costs of radial head arthroplasty versus ORIF: a database study. Hand (N Y) 2021;16:115-122. 18. Barakat A, McDonald C, Singh H. Current concepts in the management of radial head fractures: a national survey. Ann R Coll Surg Engl 2023;105:469-475. "  [Collapse]
Elshahhat A, Almekoud M. Radial head arthroplasty: A pillar of stability in complex elbow fractures. World J Orthop 2025; 16(9): 110433
4
"With the aid of deep learning, specifically the convolutional neural network, the paradigm of operator dependent endoscopy shifts ..."  [Read more]
"With the aid of deep learning, specifically the convolutional neural network, the paradigm of operator dependent endoscopy shifts towards operator independence, being one of the most important/impactful aspects of AI – assisted endoscopic analysis that this minireview focuses on. As stated in this review, there are 3 most common used models of machine learning in clinical applications. So, in order for them to perform at its’ highest capacity, one must master the ability of choosing between them for the clinical applications. Regarding image enhancement, algorithms such as GANs, U-Net variants and DnCNN, have revolutionized endoscopy. Moreover, the shift from 2D to 3D reconstruction technology, allows for on-site evaluations of disease status, therefore providing and enhanced clinical diagnosis. A probably more impactful aid AI provided in endoscopy, is the early diagnosis of malignant tumors, decrease the rate of missed diagnoses, specifically gastric cancer. Trials conducted by Shi et al (1), Arai et al (2), and Chen et al (3), reported remarkable sensitivity and specifity integrated with risk factors, thus providing providing personalized follow up strategies post upper endoscopy. However, regarding both detecting and classifying colon polyps, Namikawa et al revealed that AI showed superior sensitivity, outperforming experts, albeit with slighty less specificity in a study comparing the capabilities of AI against human experts. Having that in mind, a thorough evaluation and then integration of AI in the decision making process algorithm. As for non malignant diseases, the most importanat challenge is data heterogeneity and insufficient clinical validation. However, the application of machine learning in inflammatory bowel disease (IBD) shows promise in objective grading of IBD, in reshaping the monitoring paradigm, converging into an “active early warning” system. Moreover, AI models, benefit the IBD clinical trials, by improved endoscopy quality, consistent, valid, real -time assessment of IBD severity at site level, improved patient recruitment, increased sensitivity to responde and patient response to treatment (4). As with all important innovations, limitations arise, specifically data privacy and annotation quality that hinder model traninig. A study conducted by Buedgens et al (5) reported that weakly supervised AI systems can achieve a high performance and maintain explainability in end-to-end image analysis in GI endoscopy. This shows that manual annotations are not necessarily a bottleneck for future clinical applications of AI. Finally, in order to provide a much smoother clinical translation of machine learning, expert bodies, such as ASGE and ESGE have provided position statements as for priorities for artificial intelligence in GI endoscopy and expected value of artificial intelligence in gastrointestinal endoscopy, respectively (6,7), therefore offering standardization. "  [Collapse]
Ding JC, Zhang J. Endoscopic image analysis assisted by machine learning: Algorithmic advancements and clinical uses. Artif Intell Gastrointest Endosc 2025; 6(3): 108281
5
"The article title "B cell CLL/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through ..."  [Read more]
"The article title "B cell CLL/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through the NF-κB signaling pathway" by Xiao et al. discussed B cell CLL/lymphoma 10 promotes colorectal cancer growth and regulates the sensitivity of Colorectal cancer cells to cuproptosis by activating the NF-κB signaling pathway and modulating DLAT expression. The study provide a molecular basis for developing B cell CLL/lymphoma 10-targeted therapies for colorectal cancer. Further studies are needed to determine whether NF-κB signaling is essential for BCL10 on cuproptosis sensitivity or whether additional mechanisms are involved. Moreover, future study should explores whether NF-κB influences other cellular pathways or targets that contribute to cuproptosis sensitivity. The future study should also explores the safety and effectiveness of such therapeutic interventions. "  [Collapse]
Xiao PT, Li CF, Liu YD, Zhong J, Cui XL, Liu C, Yang W. B cell CLL/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through the NF-κB signaling pathway. World J Gastroenterol 2025; 31(34): 109825
6
"This study on the potential therapeutic effects of levodopa for liver fibrosis provides a novel perspective in the treatment of ..."  [Read more]
"This study on the potential therapeutic effects of levodopa for liver fibrosis provides a novel perspective in the treatment of hepatic conditions, particularly in the context of liver injury induced by carbon tetrachloride (CCl4) in rats. The findings are promising, showing that levodopa not only reduces fibrosis markers like collagen deposition but also modulates key signaling pathways involved in liver regeneration. These results could pave the way for repurposing levodopa in treating liver diseases, especially given the lack of universally approved treatments for liver fibrosis. "  [Collapse]
Wang HY, Qi MM, Zhang K, Zhu YZ, Zhang J. Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment. World J Gastroenterol 2025; 31(34): 108617
7
"This paper on ultrasound-guided percutaneous thermal and non-thermal ablation techniques for intrahepatic cholangiocarcinoma (iCCA) ..."  [Read more]
"This paper on ultrasound-guided percutaneous thermal and non-thermal ablation techniques for intrahepatic cholangiocarcinoma (iCCA) provides a well-rounded discussion on the safety, efficacy, and clinical indications of these advanced methods, particularly for patients who are ineligible for surgery. The article not only details the mechanisms and procedural aspects of these treatments but also critically evaluates their outcomes, such as survival rates and potential complications. It highlights how these therapies can provide an alternative to surgery, especially for patients with small, localized tumors or those with poor liver function. For clinicians, this paper serves as an important resource in understanding the evolving landscape of locoregional treatments for iCCA. It also underscores the need for personalized treatment strategies based on tumor characteristics, liver function, and patient comorbidities. In conclusion, this review effectively provides evidence-based insights into these promising ablation techniques, with an emphasis on improving patient outcomes while managing risks. "  [Collapse]
Giorgio A, Ciracì E, De Luca M, Stella G, Rollo VC, Montesarchio L, Giorgio V. Ultrasound-guided percutaneous thermal and non-thermal ablation of intrahepatic cholangiocarcinoma. World J Gastroenterol 2025; 31(34): 108623
8
"EFX, a fibroblast growth factor 21 analogue, shows promising potential for improving liver fat, liver injury markers, fibrosis, and ..."  [Read more]
"EFX, a fibroblast growth factor 21 analogue, shows promising potential for improving liver fat, liver injury markers, fibrosis, and several metabolic parameters in individuals with MASH. The paper offers significant insights, especially given the limited therapeutic options available for MASH. From a clinical standpoint, the review highlights the dual benefits of EFX in addressing both liver and metabolic dysfunctions, including improvements in hepatic fat content, liver enzymes, fibrosis markers, and insulin resistance. The finding that EFX significantly reduces liver fat while improving metabolic outcomes such as HbA1c and triglycerides is particularly relevant in the management of MASH, which often coexists with metabolic syndrome and type 2 diabetes. In conclusion, this review emphasizes EFX’s potential as a promising treatment for MASH, particularly in managing both hepatic and metabolic dysfunctions. This paper is a timely contribution to the field, providing a comprehensive understanding of EFX's role in MASH management. "  [Collapse]
Kamrul-Hasan ABM, Borozan S, Jena S, Nagendra L, Dutta D, Bhattacharya S, Islam MS, Pappachan JM. Safety and efficacy of efruxifermin in metabolic dysfunction-associated steatohepatitis: A systematic review. World J Gastrointest Pharmacol Ther 2025; 16(3): 110709
9
"The article is comprehensive, presenting both the beneficial effects and the challenges associated with GLP-1RAs, especially their ..."  [Read more]
"The article is comprehensive, presenting both the beneficial effects and the challenges associated with GLP-1RAs, especially their gastrointestinal adverse events such as nausea, vomiting, and diarrhea.From a clinical perspective, the paper underscores the need for personalized approaches in prescribing GLP-1RAs, considering the varying responses to treatment and the potential risks in certain patient populations. The authors also provide practical management strategies for these side effects, which is highly relevant for clinical practice. In summary, this paper offers a balanced view of the evolving landscape of obesity management with GLP-1RAs. It is a timely contribution to the field, especially for healthcare providers looking to enhance treatment outcomes while managing side effects effectively. "  [Collapse]
Ismail A, Amer MS, Tawheed A. Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future directions. World J Gastrointest Pharmacol Ther 2025; 16(3): 107148
10
"The article provides a comprehensive review of the interplay between endocrine disorders and liver dysfunction, offering insightful ..."  [Read more]
"The article provides a comprehensive review of the interplay between endocrine disorders and liver dysfunction, offering insightful perspectives on how various hormonal imbalances contribute to liver diseases such as metabolic liver disease and cirrhosis. From a clinical standpoint, the paper emphasizes the bidirectional nature of this relationship, with endocrine dysfunction not only exacerbating liver conditions but also liver damage impacting hormone metabolism. The article goes beyond theoretical mechanisms, proposing multidisciplinary management strategies that could improve patient outcomes, especially in conditions like non-alcoholic fatty liver disease (NAFLD) and cirrhosis. The therapeutic approaches outlined, including the integration of endocrine evaluation in liver disease care, underline the importance of a holistic treatment model for more personalized and effective interventions. Overall, this review is an essential resource for researchers and clinicians aiming to refine treatment protocols for patients with complex liver-endocrine disorders, providing a deeper understanding of the underlying pathophysiology and offering practical recommendations for integrated care. "  [Collapse]
Vargas-Beltran AM, Armendariz-Pineda SM, Martínez-Sánchez FD, Martinez-Perez C, Torre A, Cordova-Gallardo J. Interplay between endocrine disorders and liver dysfunction: Mechanisms of damage and therapeutic approaches. World J Gastroenterol 2025; 31(32): 108827
11
"This retrospective study provided a useful method using MRI and deep learning to analyze the diagnosis for liver cancer in patients ..."  [Read more]
"This retrospective study provided a useful method using MRI and deep learning to analyze the diagnosis for liver cancer in patients with better efficacy after image reconstruction. Although the statistical and flowchart data was applied to present the general map of this combined method, the critical presentation of direct image in HCC and normal group under artificial technology treatment was not enough to be displayed in the full manuscript and supplementary document. Suggest that author can provide these supportive images with feature indication for other ways such as data-bank online or subsequent demonstration submission using letter to the editor. "  [Collapse]
Wang ZZ, Song SM, Zhang G, Chen RQ, Zhang ZC, Liu R. Multiparametric magnetic resonance imaging of deep learning-based super-resolution reconstruction for predicting histopathologic grade in hepatocellular carcinoma. World J Gastroenterol 2025; 31(34): 111541
12
"PTBD and ERCP are the commonly used methods for biliary drainage. In low-income settings, advanced techniques such as EUS-guided ..."  [Read more]
"PTBD and ERCP are the commonly used methods for biliary drainage. In low-income settings, advanced techniques such as EUS-guided therapies are often unavailable, limiting clinicians' options. This study compares the efficacy of PTBD and ERCP in a low-income country. Both groups showed good therapeutic success, but the PTBD group had low clinical success. This difference may be due to the type of patients enrolled in PTBD, most likely those with Bismuth type 3/4, for which PTBD is typically used. The authors did not specify the aetiology (benign vs malignant) or the level of obstruction in their patients. Complications were more frequent in PTBD patients and were mainly non-biliary related, possibly indicating that sicker patients underwent interventions. These confounding factors should be considered before concluding that PTBD is less effective than ERCP for severe cholangitis. The outcome was based solely on the resolution of cholangitis; including the normalisation of bilirubin levels would have been more informative. "  [Collapse]
Karim MM, Moatter S, Amin M, Parkash O. Comparison of endoscopic retrograde cholangiopancreatography drainage vs percutaneous transhepatic biliary drainage in severe cholangitis: A study from low-middle income country. World J Gastrointest Pharmacol Ther 2025; 16(3): 107167
13
"The manuscript addresses a highly relevant topic and is enriched with numerous references. The distinction between management ..."  [Read more]
"The manuscript addresses a highly relevant topic and is enriched with numerous references. The distinction between management strategies for cT1–2 versus cT3–4 disease is particularly valuable. However, the actual role of interventions in the setting of pT3–4 tumors remains to be fully clarified. A broader discussion could be warranted regarding the clinical implications of omental metastases identified post-resection (on the surgical specimen) in patients with cT3–4 disease. Should this finding prompt a more complete disease staging? Could it provide a rationale for referring patients to intraperitoneal therapies (HIPEC, NIPEC, PIPAC)? We eagerly await the results of ongoing trials to better define these aspects. "  [Collapse]
Ilhan E, Yildirim M. Current debate in gastric cancer surgery: Omentectomy? World J Gastrointest Surg 2025; 17(8): 108110
14
"This timely basic study by Groover et al. (WJG 2025; 31: 104277) investigates sex‑based differences in liver expression of estrogen ..."  [Read more]
"This timely basic study by Groover et al. (WJG 2025; 31: 104277) investigates sex‑based differences in liver expression of estrogen receptors (ERα/ERβ) and tumor necrosis factor-alpha (TNF‑α), elucidating their roles in hepatitis C virus (HCV) pathogenesis. Leveraging human explant tissues from HCV-related cirrhosis and hepatocellular carcinoma (HCC) alongside normal controls, the authors perform RT‑qPCR and Western blot analyses to reveal differential expression patterns by sex and disease state. These findings advance our understanding of why HCV disease progression may diverge between males and females. The study is commendable for its focus on human tissue specimens and its dual molecular and protein-level methodology, enhancing translational relevance. Additionally, exploring both ER subtypes and TNF-α offers a multifaceted view of hormonal and inflammatory interplay in HCV-mediated liver pathology. The observations pave the way for sex-informed therapeutic strategies and risk stratification. Nonetheless, the commentary could be strengthened by more detailed insights into downstream signaling pathways, such as NF-κB or apoptosis pathways, which are alluded to but not fully dissected. Moreover, whether the observed ER and TNF-α alterations are causative or reactive remains open. Future investigations integrating functional assays, prospective cohorts, and multi-omics profiling would significantly bolster mechanistic clarity and clinical translation. In summary, Groover et al. deliver a valuable contribution linking sex-specific molecular expression to HCV pathogenesis, highlighting promising directions for future research. "  [Collapse]
Groover S, Addison S, Nicks S, Mwangi M, Brooks A, Kaul A, Kaul R. Sex based relative expression of estrogen receptors and tumor necrosis factor-alpha in liver affects hepatitis C virus viral pathogenesis. World J Gastroenterol 2025; 31(32): 104277
15
"This review takes the bidirectional relationship between the endocrine system and liver function as its starting point and ..."  [Read more]
"This review takes the bidirectional relationship between the endocrine system and liver function as its starting point and systematically outlines the roles of the thyroid, parathyroid, pancreas, adrenal glands, and sex hormones in liver diseases. It not only summarizes the interactions between common endocrine disorders (such as hypothyroidism, insulin resistance, and Cushing’s syndrome) and hepatic injury, but also provides mechanistic insights into key processes, including lipid metabolism disorders, oxidative stress, and hormone conversion. In addition, the article discusses emerging therapeutic approaches, highlighting the potential of TRβ agonists, GLP-1 receptor agonists, and SGLT2 inhibitors. By emphasizing the mutual reinforcement between endocrine disorders and liver diseases, this review offers valuable references for clinicians in the management of MASLD/NASH, cirrhosis, and hormone-related conditions. Importantly, it reminds us that future strategies for liver disease treatment should not be confined to the liver itself, but must also integrate the broader endocrine context. Nevertheless, the review also has certain limitations. Some sections remain primarily descriptive and observational, with relatively limited exploration of molecular pathways and immune-metabolic interactions. Furthermore, the discussion of sex hormones and the parathyroid axis is relatively brief and lacks incorporation of the latest clinical evidence. Looking ahead, integration of multi-omics technologies with large-scale clinical datasets will be essential to further advance knowledge in this field and to promote the development of interdisciplinary diagnostic and therapeutic strategies. "  [Collapse]
Vargas-Beltran AM, Armendariz-Pineda SM, Martínez-Sánchez FD, Martinez-Perez C, Torre A, Cordova-Gallardo J. Interplay between endocrine disorders and liver dysfunction: Mechanisms of damage and therapeutic approaches. World J Gastroenterol 2025; 31(32): 108827
16
"Dear Author, We read with great interest the case report by Zhang et al. describing a rare invasive inflammatory fibrotic polyp (IFP) ..."  [Read more]
"Dear Author, We read with great interest the case report by Zhang et al. describing a rare invasive inflammatory fibrotic polyp (IFP) of the duodenum with subserosal involvement. This first documented case of duodenal IFP extending beyond the muscularis propria (Figure 5A) provides valuable insights into the potential invasiveness of this entity. However, two key limitations warrant attention to enhance the clinical applicability of this finding: The preoperative evaluation revealed limitations: Biopsy limitations: Initial endoscopic biopsies yielded only necrotic tissue, failing to sample viable tumor areas (Figure 1). EUS-FNA not attempted: Despite EUS identifying muscularis propria involvement (Figure 2), fine-needle aspiration (FNA) was not performed to obtain diagnostic material. This led to misdiagnosis as a stromal tumor and unnecessary radical surgery (distal gastrectomy + lymphadenectomy). Current guidelines recommend EUS-FNA for submucosal duodenal masses to avoid overtreatment[1]. As shown in Figure 2B, the lesion size (37.1 mm × 24.5 mm) was amenable to FNA, which could have provided adequate tissue for CD34/SMA immunohistochemistry and potentially prevented surgery. In conclusion, this case report fills the gap in the understanding of invasive duodenal IFP, but the above aspect need further improvement to better reveal the biological nature of the lesion and guide clinical practice. We look forward to seeing more in-depth studies on this rare disease in the future. "  [Collapse]
Zhang FM, Ning LG, Wang JJ, Zhu HT, Feng MB, Chen HT. Invasive inflammatory fibrotic polyp of the duodenum: A case report. World J Gastrointest Surg 2025; 17(8): 107558
17
"Dear Editor, We read with great interest the article “Changes in liver and spleen stiffness after transjugular intrahepatic ..."  [Read more]
"Dear Editor, We read with great interest the article “Changes in liver and spleen stiffness after transjugular intrahepatic portosystemic shunt and their relationship with prognosis” by Liu et al. This study provides valuable insights into the dynamic changes of liver and spleen stiffness post-transjugular intrahepatic portosystemic shunt (TIPS) and their prognostic value, filling an important gap in non-invasive monitoring of TIPS outcomes. However, three aspects could be further refined to enhance the study’s clinical relevance and evidence robustness. First, the study lacks analysis of the impact of TIPS shunt patency on changes in liver and spleen stiffness. The authors report that spleen stiffness decreases significantly post-TIPS and correlates with portal pressure gradient (PPG), but they do not clarify whether these stiffness changes are influenced by shunt function (e.g., stenosis or occlusion). Clinically, TIPS shunt dysfunction (a common complication) can lead to re-elevated portal pressure, which may reverse the initial reduction in spleen stiffness. Without documenting shunt patency status (e.g., via Doppler ultrasound or venography) at each follow-up time point and stratifying stiffness trends by patency, it is difficult to determine whether the observed stiffness changes are purely due to TIPS-induced hemodynamic improvement or confounded by shunt dysfunction. This gap limits the ability to interpret stiffness trends as reliable indicators of long-term TIPS efficacy. Second, the study does not explore the relationship between changes in liver/spleen stiffness and the severity of overt hepatic encephalopathy (OHE). Although logistic regression shows no correlation between baseline stiffness and post-TIPS OHE, the dynamic changes in stiffness (e.g., the magnitude of spleen stiffness reduction) may still be associated with OHE risk. For example, a more pronounced decrease in spleen stiffness might reflect better portal decompression, potentially reducing the risk of OHE by altering gut-liver axis function or ammonia metabolism. Additionally, the study only includes OHE of grade ≥2, excluding milder grades (grade 1), which are clinically relevant for early intervention. Analyzing stiffness changes in relation to OHE severity and including all OHE grades would provide a more comprehensive understanding of how stiffness correlates with this key TIPS complication. Third, the study’s subgroup analysis of liver cirrhosis etiology is insufficient to inform the etiology-specific prognostic value of stiffness. The cohort includes patients with viral, alcoholic, and immunological cirrhosis, but the authors do not stratify survival outcomes or stiffness trends by etiology. Previous studies have shown that cirrhosis etiology affects liver stiffness progression and TIPS prognosis—for instance, alcoholic cirrhosis may be associated with more rapid stiffness changes due to ongoing inflammation, compared to viral cirrhosis. Without etiology-specific subgroup analyses, it is unclear whether the identified liver stiffness cutoff (35.15 kPa) or the prognostic role of stiffness applies uniformly across different etiologies. This limits the study’s ability to guide personalized TIPS assessment for patients with distinct cirrhosis causes. In conclusion, Liu et al.’s work makes a meaningful contribution to non-invasive monitoring of TIPS outcomes. Addressing the above issues—by integrating shunt patency data, analyzing stiffness changes with OHE severity, and exploring etiology-specific effects—would further strengthen the study’s scientific rigor and clinical utility. We look forward to seeing supplementary analyses or follow-up studies to address these points. Sincerely, Xiong Yuezhihong Yichang Central People's Hospital "  [Collapse]
Liu XF, Huang XC, Ye QJ, Yuan LJ, Gao GF, Li JY, Feng DP. Changes in liver and spleen stiffness after transjugular intrahepatic portosystemic shunt and their relationship with prognosis. World J Gastrointest Surg 2025; 17(8): 109884
18
"Dear Editor, We read with great interest the article “Morphomics in esophageal cancer: Validation and association with muscular and ..."  [Read more]
"Dear Editor, We read with great interest the article “Morphomics in esophageal cancer: Validation and association with muscular and cardiorespiratory fitness” by Tseng et al. This study innovatively explores the correlation between computed tomography (CT)-based morphomics and functional assessments (bioelectrical impedance analysis [BIA], hand grip strength [HGS], cardiopulmonary exercise testing [CPET]) in esophageal cancer patients, providing valuable evidence for preoperative physical fitness evaluation. However, three aspects could be further refined to enhance the study’s clinical applicability and evidence robustness. First, the study lacks analysis of the impact of tumor stage and neoadjuvant therapy on the relationship between morphomics and functional indicators. The cohort includes newly diagnosed esophageal cancer patients, but the article does not specify the distribution of tumor stages (e.g., T stage, N stage) or whether patients received neoadjuvant chemotherapy/radiotherapy before CT and functional assessments. Clinically, advanced tumor stages may directly affect muscle mass (via malnutrition or tumor-related inflammation), while neoadjuvant therapy can cause treatment-related muscle loss (cachexia) or changes in cardiorespiratory fitness. Without stratifying outcomes by tumor stage or adjusting for neoadjuvant therapy status, it is difficult to determine whether the observed correlations between morphomics (e.g., dorsal muscle group [DMG] volume) and CPET/BIA results are confounded by these factors. This gap limits the ability to generalize the findings to patients at different disease stages or treatment phases. Second, the study does not clarify the clinical significance of morphomic parameter thresholds for predicting low cardiorespiratory fitness (CRF). The authors report that morphomics (combining bone mineral density [BMD], visceral fat [VF] area, and DMG volume) predicts low ventilatory anaerobic threshold normalized by body weight (VAT/BW < 11 mL/kg/min) with an optimism-corrected AUC of 0.778. However, they do not provide specific cutoff values for the key morphomic variables (e.g., how much VF area or DMG volume increases/decreases the risk of low CRF) or validate these thresholds in clinical practice. For example, if a VF area > X cm² or DMG volume < Y cm³ is associated with a significantly higher risk of low CRF, such thresholds would help clinicians quickly identify high-risk patients via routine CT scans. Without defining these actionable cutoffs, the predictive model’s practical value for preoperative screening remains limited. Third, the homogeneity of the cohort (98% male, Taiwanese population) raises concerns about generalizability, yet the study does not discuss or address potential sex- or ethnicity-related differences in morphomics-functional correlations. Previous studies have shown that body composition (e.g., muscle-fat distribution) and its association with physical fitness vary by sex—for instance, women may have different muscle density thresholds or fat-mass impacts on CRF compared to men. Additionally, ethnic differences in body composition (e.g., Asian vs. Western populations) could affect morphomic parameter norms and their correlation with BIA/CPET results. By excluding female patients and focusing solely on a Taiwanese cohort, the study’s findings may not apply to more diverse populations. Exploring sex-stratified analyses (if feasible with additional data) or acknowledging these limitations with suggestions for multicenter, multiethnic validation would strengthen the study’s external validity. In conclusion, Tseng et al.’s work makes a meaningful contribution to integrating morphomics into esophageal cancer preoperative assessment. Addressing the above issues—through stratification by tumor stage/neoadjuvant therapy, defining clinical thresholds for predictive morphomic parameters, and expanding cohort diversity—would further enhance the study’s scientific rigor and clinical translational value. We look forward to seeing supplementary analyses or follow-up studies to address these points. Sincerely, Xiong Yuezhihong Yichang Central People's Hospital "  [Collapse]
Tseng WHS, Huang SC, Wang SC, Lin J, Zhang P, Liu YC, Chao YK, Chiu CH. Morphomics in esophageal cancer: Validation and association with muscular and cardiorespiratory fitness. World J Gastrointest Surg 2025; 17(8): 108600
19
"Dear Editor, We read with great interest the article “Outcomes of iodine-125 seed strips combined with double self-expandable metallic ..."  [Read more]
"Dear Editor, We read with great interest the article “Outcomes of iodine-125 seed strips combined with double self-expandable metallic stent for Bismuth type III and IV malignant biliary obstruction” by Zhou et al. This study pioneers the evaluation of a novel combination therapy for advanced hilar malignant biliary obstruction (MBO), a clinical challenge with limited treatment options, and reports promising technical success and safety profiles. However, three aspects could be further clarified or expanded to enhance the study’s validity and clinical translational value. First, the study lacks subgroup analysis of outcomes based on stent configuration types and primary disease etiology. The authors employed four stent configurations (Type X, T, Y, and Tandem) tailored to different biliary obstruction patterns, yet they did not compare key endpoints—such as median overall survival (OS), stent patency, or complication rates—across these configurations. For example, Type Y stents (used in 41.2% of patients) may have distinct drainage efficiency or patency durability compared to Tandem stents, which could guide clinicians in selecting the optimal configuration for specific Bismuth subtypes. Additionally, the cohort includes patients with diverse primary diseases (13 with hilar cholangiocarcinoma, 2 with gallbladder cancer liver metastasis, etc.), but no analysis was conducted to determine if the therapy’s efficacy varies by tumor type. Given that different malignancies have distinct biological behaviors (e.g., gallbladder cancer tends to be more aggressive than hilar cholangiocarcinoma), stratifying outcomes by etiology would help identify patient subgroups most likely to benefit from this treatment. Second, the impact of concurrent systemic anticancer therapy on survival outcomes was not adequately addressed. The study mentions that 6 of 17 patients received sequential systemic treatments (e.g., lenvatinib, hepatic artery infusion chemotherapy). These therapies are known to improve survival in advanced biliary tract cancers, yet the current analysis does not adjust for their potential confounding effect—for instance, whether patients receiving systemic therapy had longer OS independent of the combination stent-seed treatment. Without subgroup comparisons (e.g., OS between patients with vs. without concurrent systemic therapy) or multivariate analysis incorporating these treatments as covariates, it is difficult to isolate the true efficacy of the 125I seed strip-double stent regimen. This gap limits the ability to conclude whether the observed survival benefit (median OS 189 days) is primarily driven by the local intervention or concurrent systemic therapy. Third, the study provides insufficient details on long-term radiation-related safety and late complications. While the authors report no severe early complications and only one case of seed strip migration, they do not mention long-term monitoring for radiation-induced adverse events—such as bile duct stricture progression, liver parenchyma damage, or secondary malignancies—despite 125I’s half-life of 60.1 days and cumulative absorbed dose of 82.3–83.6 Gy. Additionally, the definition of “late complications” is unclear, and the follow-up period (final follow-up July 31, 2023) is not specified in terms of median duration for surviving patients. For a therapy involving radioactive seeds, documenting long-term radiation safety (e.g., imaging evidence of liver injury, changes in liver function over time) is critical to assessing its overall risk-benefit profile, especially for patients with prolonged survival (e.g., the 3 surviving patients with patent stents). In summary, Zhou et al.’s study makes a valuable contribution to the management of advanced hilar MBO by introducing a novel combination therapy. Addressing the above issues—through subgroup analyses of stent configurations and etiology, adjustment for concurrent systemic therapy, and detailed long-term safety monitoring—would further strengthen the study’s evidence base and provide more actionable guidance for clinical practice. We look forward to seeing supplementary data or follow-up studies to address these points. Sincerely, Xiong Yuezhihong Yichang Central People's Hospital "  [Collapse]
Zhou CG, Zhang Y, Li H, Liu KY, Yang XY, Gao K. Outcomes of iodine-125 seed strips combined with double self-expandable metallic stent for Bismuth type III and IV malignant biliary obstruction. World J Gastrointest Surg 2025; 17(8): 108579
20
"Dear Editor, We read with great interest the article “Prevalence of sarcopenia in patients with surgical obstructive jaundice and ..."  [Read more]
"Dear Editor, We read with great interest the article “Prevalence of sarcopenia in patients with surgical obstructive jaundice and its impact on clinical outcomes” by Zhang et al. This study provides valuable insights into the association between obstructive jaundice and sarcopenia, as well as the subsequent effects on postoperative outcomes, which fills an important gap in clinical research on hepatobiliary-pancreatic diseases. However, three aspects could be further refined to enhance the depth of evidence and clinical applicability of the findings. First, the study lacks analysis of the impact of preoperative biliary drainage (PBD) on sarcopenia and postoperative outcomes. The article mentions that PBD is recommended for patients with total bilirubin (TBIL) levels exceeding 34-51 μmol/L, yet it does not specify how many patients in the obstructive jaundice group underwent PBD, nor does it explore whether PBD affects sarcopenia-related indicators (such as grip strength, walking speed, and appendicular skeletal muscle index) or modifies the association between jaundice severity and sarcopenia. Clinically, PBD can alleviate cholestasis, improve nutritional absorption, and reduce systemic inflammation—factors that may mitigate muscle loss. Without stratifying outcomes by PBD status, it is difficult to determine whether PBD could serve as an intervention to reduce sarcopenia risk in patients with severe jaundice, which limits the study’s guidance for preoperative management. Second, the correlation between sarcopenia and long-term outcomes (e.g., in-hospital mortality, long-term survival) was not investigated. The current analysis focuses on short-term outcomes such as postoperative hospital stay and complication rates, but it does not mention in-hospital mortality data or follow-up results beyond discharge. Previous studies have shown that sarcopenia is associated with reduced long-term survival in patients undergoing abdominal surgery, such as hepatectomy or pancreaticoduodenectomy. For patients with obstructive jaundice (especially those with malignant etiologies), clarifying whether sarcopenia predicts long-term prognosis would provide more comprehensive evidence for clinical decision-making—for example, guiding the intensity of follow-up or the need for long-term nutritional interventions. The absence of such data weakens the study’s ability to address the full clinical impact of sarcopenia. Third, the study does not explore the potential mediating role of inflammatory or nutritional biomarkers in the relationship between obstructive jaundice and sarcopenia. The discussion hypothesizes that jaundice-induced inflammation (e.g., elevated TNF-α, IL-6) and malnutrition contribute to muscle loss, but the study did not measure these biomarkers (e.g., cytokine levels, vitamin D, or amino acid profiles) or analyze their mediating effects. For instance, if patients with severe jaundice have higher IL-6 levels that are independently associated with sarcopenia, this would support inflammation as a key mechanism linking jaundice to muscle wasting. Without such analyses, the proposed pathophysiological pathway remains speculative, and it is difficult to identify potential targets for interventions (e.g., anti-inflammatory therapies or vitamin D supplementation) to prevent sarcopenia in this population. In conclusion, Zhang et al.’s study makes a meaningful contribution to understanding the prevalence and short-term impact of sarcopenia in patients with obstructive jaundice. Addressing the above issues would further strengthen the study’s scientific rigor and clinical relevance, providing more actionable guidance for preoperative assessment and intervention in this patient group. We look forward to seeing supplementary analyses or follow-up studies to address these points. Sincerely, Xiong Yuezhihong Yichang Central People's Hospital "  [Collapse]
Zhang RN, Cui JY, Zhao ZH, Li YT, Liu ZW, Zhang JY, Wei Q, Lu YM, Chen QP. Prevalence of sarcopenia in patients with surgical obstructive jaundice and its impact on clinical outcomes. World J Gastrointest Surg 2025; 17(8): 107209
1070 items  Read more >>
Write to the Help Desk
  • ALL AUTHOR RESOURCES
  • Appeals and Complaints
  • Article Processing Charge
  • Common Usage of Quantities and Units
  • Copyright License Agreement
  • Create an Account
  • Criteria for Authorship
  • Ethics Committee of BPG
  • Ethics Statements
  • Guidelines for Authors
  • Journals
  • Language Editing Process for Manuscripts Submitted by Non-Native Speakers of English
  • Methods of Post-Publication Debate
  • Open-Access
  • Policies on Handle Allegations from Whistleblowers
  • Publication Misconduct
  • Quality of Publications
  • Steps for Submitting Manuscripts
  • Submit a Manuscript
  • ALL PEER-REVIEWER RESOURCES
  • Manuscript Decision
  • Peer-Review Process
  • Peer-Reviewer Tracking for Manuscripts
  • Reviewer Acknowledgment
  • REFERENCE CITATION ANALYSIS
  • Find a Category
  • Find a Journal
  • Find a Scholar
  • Find an Academic Assistant
  • Find an Article
  • Find an Article PDF
  • Subscribe
  • Today's Articles
  • ALL PUBLISHER RESOURCES
  • About the BPG
  • BPG Home
  • Company Registration
  • Contact Us
  • ICMJE Conformity
  • Management Team
  • Membership
  • Ownership
  • Permissions
  • Privacy Policy
  • Publication Ethics
  • Publisher
  • Publishing Credentials
  • Revenue Sources
  • Special Statement
  • Terms of Use
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345